Author: Putri

TOKYO, June 3, 2025 - (JCN Newswire via SeaPRwire.com) - Fujitsu Limited today announced a new business strategy to accelerate the digital transformation of financial institutions and contribute to solving societal issues by shifting its business model and portfolio towards service-based offerings.The financial industry is changing at an unprecedented pace. In addition to the progress of digitalization in financial operations, including the shift to cashless transactions and automation of business processes, non-financial businesses are expanding their efforts to provide customers with financial services by integrating them into their own services. Consumers will continue to benefit from financial services, and further innovation is likely through collaboration between financial institutions and businesses in other sectors.Fujitsu aims to enrich lives by creating a smart society through the continuous evolution of reliable accounting and branch solutions, and by leveraging the data they generate. To achieve this goal, Fujitsu has newly systematized initiatives focused on the financial industry, leveraging Fujitsu Uvance. This service will combine its deep expertise in financial operations with the advanced capabilities of Fujitsu Uvance, leveraging cutting-edge technologies and open architecture, including AI.Financial industry-focused initiatives with Uvance offer the following key solutions, which will be gradually expanded in stages:1. Fujitsu’s core banking solution: A new core accounting solution with flexibility and scalabilityFujitsu’s core banking solution is a cloud-native core banking solution that addresses challenges of flexibility and scalability. The open API function enables the integration with external services, and this architecture aims to automate system development using generative AI technology in the future.2. Fujitsu’s digital channel services: A store solution seamlessly integrating in-person and remote interactions while streamlining operationsFujitsu’s digital channel services is a store solution that supports the transformation of business operations, customer experience, and work styles by turning the financial front function of customer contact into a service in order to evolve bank branches into hubs for rapid decision-making through the use of AI. The solution provides integrated management of digital channel operations and cash-based procedures, enabling streamlined operations through seamless integration of remote and in-person interactions.Through the provision of financial industry-focused initiatives with Uvance, Fujitsu will help to enhance the operations of financial institutions and advance the realization of a more prosperous society.Termination of ATM and branch-specific hardware provisioningFujitsu further announced its decision to conclude the provision of its own ATMs and branch-specific hardware business in Japan by the end of March 2028. Aligned with its strategic focus on accelerating financial digital transformation through service-based business, Fujitsu has reached a basic agreement with OKI Electric Industry Co., Ltd. for hardware procurement. This collaboration will ensure the continued provision of hardware, complementing Fujitsu's software offerings. Fujitsu will also continue to offer optimal hardware solutions for convenience store ATMs in Japan.Fujitsu’s Commitment to the Sustainable Development Goals (SDGs)The Sustainable Development Goals (SDGs) adopted by the United Nations in 2015 represent a set of common goals to be achieved worldwide by 2030.Fujitsu’s purpose — “to make the world more sustainable by building trust in society through innovation” — is a promise to contribute to the vision of a better future empowered by the SDGs.About FujitsuFujitsu’s purpose is to make the world more sustainable by building trust in society through innovation. As the digital transformation partner of choice for customers around the globe, our 113,000 employees work to resolve some of the greatest challenges facing humanity. Our range of services and solutions draw on five key technologies: AI, Computing, Networks, Data & Security, and Converging Technologies, which we bring together to deliver sustainability transformation. Fujitsu Limited (TSE:6702) reported consolidated revenues of 3.6 trillion yen (US$23 billion) for the fiscal year ended March 31, 2025 and remains the top digital services company in Japan by market share. Find out more: global.fujitsu.Press ContactsFujitsu LimitedPublic and Investor Relations DivisionInquiries Copyright 2025 JCN Newswire via SeaPRwire.com.

TOKYO, June 3, 2025 - (JCN Newswire via SeaPRwire.com) - Anime Tokyo Station is an anime exhibition site focused on Japanese anime content, which has developed a devoted fan base around the world. It attracts 167,410 visitors (as of May 18, 2025), children and adults alike, from both Japan and overseas. We are pleased to announce the launch of the official Anime Tokyo Station YouTube channel, along with the release of a new promotional video narrated by renowned voice actor Akio Otsuka, introducing the facility.Promotional video narrated by Akio OtsukaAs you wander freely through the interior spaces of Anime Tokyo Station, you’ll encounter striking symbolic displays, special exhibitions that showcase the appeal of Japanese anime, archived materials, and a variety of services on each floor. Enjoy a leisurely tour of the facility with narration by renowned voice actor Akio Otsuka.Going forward, the official Anime Tokyo Station YouTube channel will regularly share new videos, including further introductions to the facility, as well as coverage of special exhibitions, workshops, and events. The channel aims to serve as a hub for anime exhibitions and keep viewers informed about Anime Tokyo Station’s ongoing initiatives.YouTube overviewChannel name: Anime Tokyo Station Official ChannelChannel URL: https://www.youtube.com/channel/UCSJOjGJE5Yiqw3PZ97AVdJwFacility Introduction Video: https://www.youtube.com/watch?v=1jp-OK_Kfe8Venue Overview- Name: Anime Tokyo Station (also known as "Anime Tokyo")- Location: Floors B1 to 2F of Tokyu East 5 (2-25-5 Minami-Ikebukuro, Toshima-ku, Tokyo)*4 minutes on foot from the East Exit of Ikebukuro Station- Hours: 11:00 a.m. to 7:00 p.m. (last admission: 6:45 p.m.)- Closed: Mondays*If Monday falls on a holiday, the venue will be open on Monday and closed on the following dayNew Year's holiday periodMay be closed on other daysPlease check the venue website before coming.- Admission fee: Free- Website: https://animetokyo.jp/en/ Inquiries regarding this press releasePublic Relations Office of "Anime Tokyo Station" (Kyodo PR)Contact person: Miri YasudaE-mail: animetokyo-pr@kyodo-pr.co.jpPress release: https://www.acnnewswire.com/docs/files/20250603.pdf Copyright 2025 JCN Newswire via SeaPRwire.com.

Strasbourg, France & Tokyo, Japan, June 2, 2025 - (JCN Newswire via SeaPRwire.com) - Transgene (Euronext Paris: TNG), a biotech company that designs and develops virus-based immunotherapies for the treatment of cancer, and NEC Corporation (NEC; TSE: 6701), a leader in IT, network and AI technologies, have presented new positive data on TG4050 in a rapid oral presentation at the American Society of Clinical Oncology (ASCO) Annual Meeting.These positive data confirm that individualized neoantigen therapeutic vaccine TG4050 is safe and feasible in the adjuvant setting of resectable HPV-negative locally advanced head and neck squamous cell carcinoma (HNSCC). TG4050 induces, as monotherapy, long-lasting immune responses to vaccine neoantigens sustained for up to 2 years, and these results met all trial endpoints (NCT04183166) including safety, feasibility, immune activation and disease-free survival (defined as survival without recurrence or death for any cause).TG4050 is based on Transgene’s myvac® platform and powered by NEC’s cutting-edge AI capabilities designed to optimize antigen selection.Positive data from Phase I, confirming proof of principle of Transgene’s viral vector based individualized cancer vaccine TG4050 in HPV-negative locally advanced head and neck cancer 100% disease free survival at a minimum of 2-year follow-up of treated patients (median follow-up: 30 months) in the Phase I part of the trial: all patients in the TG4050 treatment arm remain disease free while 3 patients in the observational arm have relapsed.Persistence of neoantigen-specific CD8+ T cell responses over 2 years after the start of TG4050 has been observed.Dr. Alessandro Riva, CEO of Transgene, commented: "The sustained clinical and immunogenicity outcomes observed over two years of TG4050 monotherapy, along with the positive safety profile, mark an important milestone for Transgene. These results reinforce both the clinical promise of TG4050 and our commitment to accelerate the development of this individualized immunotherapy in adjuvant setting for patients with HPV-negative, locally advanced head and neck cancer."Motoo Nishihara, Corporate EVP and CTO at NEC, commented: "This positive readout, combined with the durability of the efficacy data at two years, underscore the clinical potential of individualized cancer vaccine programs. It is a strong validation of our innovative AI platform and our dedication to advancing solutions that deliver meaningful, long-term value to patients and healthcare systems alike."Ongoing Phase II part of Phase I/II clinical trial of individualized neoantigen therapeutic cancer vaccine TG4050TG4050 is being evaluated in a randomized multicenter Phase I/II trial as a single agent in the adjuvant treatment of HPV-negative head and neck cancers (NCT04183166). Based on the promising data obtained in the Phase I part of the trial, Transgene and NEC extended the joint development of TG4050 in this indication with a Phase II extension of the trial.The Phase II part of the trial, aimed at confirming the encouraging results in a larger patient population and evaluating both immunological and clinical outcomes, is currently underway. All patients are expected to be randomized by Q4 2025. Altogether, the Phase I/II study will comprise approximately 80 patients.A conference call in English is scheduled June 6, 2025, at 3:00 p.m. CET. (9:00 a.m. ET)Webcast link to English language conference call: https://edge.media-server.com/mmc/p/x49uzc62 Please log in to the following link to obtain your personal telephone IDs: https://register-conf.media-server.com/register/BId8c981041ca84dad92bb2faa73fc5344 A replay of the call will be available on the Transgene website (www.transgene.com) following the live event.About TransgeneTransgene (Euronext: TNG) is a biotechnology company focused on designing and developing targeted immunotherapies for the treatment of cancer. The Company’s clinical-stage programs consist of a portfolio of viral vector-based immunotherapeutics. TG4050, the first individualized therapeutic vaccine based on the myvac® platform is the Company’s lead asset, with demonstrated proof of principle in patients in the adjuvant treatment of head and neck cancers. The portfolio also includes other viral-vector-based immunotherapies: TG4001 for the treatment of HPV-positive cancers, as well as BT-001 and TG6050, two oncolytic viruses based on the Invir.IO® viral backbone. The Company also conducts innovative discovery and preclinical work, aimed at developing novel viral vector-based modalities.With Transgene’s myvac® platform, therapeutic vaccination enters the field of precision medicine with a novel immunotherapy that is fully tailored to each individual. The myvac® approach allows the generation of a virus-based immunotherapy that encodes patient-specific mutations identified and selected by Artificial Intelligence capabilities provided by its partner NEC.With its proprietary platform Invir.IO®, Transgene is building on its viral vector engineering expertise to design a new generation of multifunctional oncolytic viruses.Additional information about Transgene is available at: www.transgene.com Follow us on social media: X (formerly Twitter): @TransgeneSA — LinkedIn: @Transgene — Bluesky: @TransgeneAbout myvac®myvac® is a viral vector (MVA – Modified Vaccinia Ankara) based, individualized immunotherapy platform that has been developed by Transgene to target solid tumors. myvac®-derived products are designed to stimulate the patient’s immune system to recognize and destroy tumors using their own cancer specific genetic mutations. Transgene has set up an innovative network that combines bioengineering, digital transformation, established vectorization know-how and unique manufacturing capabilities. Transgene has been awarded "Investment for the Future" funding from Bpifrance for the development of its platform myvac®. TG4050 is the first myvac®-derived product being evaluated in clinical trials. Click here to watch a short video on myvac.About TG4050TG4050 is an individualized immunotherapy being developed for solid tumors that is based on Transgene’s myvac® technology and powered by NEC’s longstanding artificial intelligence (AI) and machine learning (ML) expertise. This virus-based therapeutic vaccine encodes neoantigens (patient-specific mutations) identified and selected by NEC’s Neoantigen Prediction System. The prediction system is based on more than two decades of expertise in AI and has been trained on proprietary data allowing it to accurately prioritize and select the most immunogenic sequences.TG4050 is designed to stimulate the immune system of patients in order to induce a T-cell response that is able to recognize and destroy tumor cells based on their own neoantigens. This individualized immunotherapy is developed and produced for each patient.About the Phase I/II clinical trialTG4050 is being evaluated in a Phase I/II clinical trial for patients with HPV-negative head and neck cancers (NCT04183166). An individualized treatment is created for each patient after they complete surgery and while they receive adjuvant therapy. Half of the participants received their vaccine immediately after completing adjuvant treatment. The other half were given TG4050 as an additional treatment at the time of recurrence of the disease as an additional treatment to standard of care (SoC). This randomized study is evaluating the treatment benefits of TG4050 in patients who are at risk of relapse. In the Phase I part, thirty-two evaluable patients have been included. The Phase II part is currently enrolling patients internationally.About NEC’s Neoantigen Prediction SystemNEC’s neoantigen prediction system utilizes its proprietary AI, such as graph-based relational learning, trained on multiple sources of biological data to discover candidate neoantigen targets. These targets are carefully analyzed using proprietary machine learning algorithms that include in-house HLA binding and antigen presentation AI tools to evaluate the likelihood of eliciting a robust and clinically relevant T-cell response. With NEC OncoImmunity now on board, NEC continues to strengthen its top-class neoantigen prediction pipelines with the aim of maximizing the therapeutic benefits of personalized cancer immunotherapy for patients worldwide.For more information, please visit NEC Bio at https://www.nec-bio.com or https://www.nec-bio.com/en_DD/research-and-innovation/our-approach/ About NEC CorporationNEC Corporation has established itself as a leader in the integration of IT and network technologies while promoting the brand statement of “Orchestrating a brighter world.” NEC enables businesses and communities to adapt to rapid changes taking place in both society and the market as it provides for the social values of safety, security, fairness and efficiency to promote a more sustainable world where everyone has the chance to reach their full potential.For more information, visit NEC at https://www.nec.com. DisclaimerThis press release contains forward-looking statements, which are subject to numerous risks and uncertainties, which could cause actual results to differ materially from those anticipated. The occurrence of any of these risks could have a significant negative outcome for the Company’s activities, perspectives, financial situation, results, regulatory authorities’ agreement with development phases, and development. The Company’s ability to commercialize its products depends on but is not limited to the following factors: positive pre-clinical data may not be predictive of human clinical results, the success of clinical studies, the ability to obtain financing and/or partnerships for product manufacturing, development and commercialization, and marketing approval by government regulatory authorities. For a discussion of risks and uncertainties which could cause the Company’s actual results, financial condition, performance or achievements to differ from those contained in the forward-looking statements, please refer to the Risk Factors ("Facteurs de Risque") section of the Universal Registration Document, available on the AMF website (https://www.amf-france.org) or on Transgene’s website (www.transgene.fr). Forward-looking statements speak only as of the date on which they are made, and Transgene undertakes no obligation to update these forward-looking statements, even if new information becomes available in the future. Copyright 2025 JCN Newswire via SeaPRwire.com.

TOKYO, June 2, 2025 - (JCN Newswire via SeaPRwire.com) - Eisai Co., Ltd. announced today the launch of “Pariet®S” (pharmaceutical requiring guidance), which is highly effective in alleviating severe heartburn andstomach pain caused by gastric acid reflux, at pharmacies and drugstores throughout Japan.(1)"Pariet S" is the first proton pump inhibitor (PPI(2)) to receive manufacturing and marketing approval as an over the counter (OTC) medicine in Japan. Rabeprazole sodium, in an amount equivalent to that used in the prescription product(3), works directly on the proton pumps that produce stomach acid, effectively alleviating severe heartburn caused by gastric acid reflux and stomach pain due to excessiveacid secretion. The medicine comes in small, easy-to-swallow tablets, with a once-daily dosage providing 24-hour relief.Rabeprazole sodium, the active ingredient in “Pariet S”, is a PPI developed at Eisai’s Tsukuba Research Laboratories. The medicine was first launched in Japan in 1997 as a prescription pharmaceutical underthe brand name “Pariet” and has since been approved more than 100 countries worldwide. It is widely prescribed to people struggling with acid-related disorders.In recent years, there is a tendency for increased stomach acid secretion due to disrupted eating habits, stress, and a decline in the infection rate of Helicobacter pylori. Moreover, the number of individuals experiencing gastric acid reflux has grown, driven by age-related weakening of the lower esophageal sphincter. Eisai will introduce “Pariet S” as a new treatment option in the OTC gastric medication market, aiming to alleviate sever heartburn and discomfort caused by gastric acid related conditions, and strongly support people in the daily living domain who wish for a comfortable and secure daily life.For further details, please refer to the product’s website for details about "Pariet S" (Japanese only) https://www.eisai.jp/products/pariet/pariets(1) "Pariet S" is classified as a drug that requires a pharmacist’s guidance at the time of sale(2) Proton Pump Inhibitor suppresses gastric acid secretion by inhibiting the “proton pump” which is the final step in the secretion process.(3) Contains rabeprazole10mg per tabletMedia Inquiries:Public Relations DepartmentEisai Co., Ltd.+81-(0)3-3817-5120 Copyright 2025 JCN Newswire via SeaPRwire.com.

TOKYO, June 2, 2025 - (JCN Newswire via SeaPRwire.com) - Mitsubishi Corporation (“MC”) has agreed to acquire shares in DEScycle Ltd., a company known for its innovative technology in metal recovery from e-scrap. The two companies will also enter into a strategic business partnership to foster collaboration.E-scrap contains valuable materials such as copper and precious metals, and its value as an urban mine has grown in recent years. With the continued integration of AI into society, the rapid expansion of data centers is expected to increase the volume of e-scrap. However, due to the challenges of achieving clean and cost-effective recycling, a large portion of e-scrap is still disposed of in landfills, raising serious environmental concerns.DEScycle's proprietary technology* enables to selectively dissolve metals at room temperature and atmospheric pressure, and is expected recover metals with significantly lower energy consumption and environmental impact compared to conventional smelting methods. By effectively utilizing e-scrap as a secondary resource, it contributes to sustainable resource circulation.The funds raised by DEScycle will support the construction and operation of a pilot plant in the UK. Following the demonstration phase, a commercial-scale plant with an annual processing capacity of approximately 5,000 tons is scheduled to begin operations in the UK in 2028, with plans to further expand to North America, Japan, and other regions.MC will leverage its trading expertise and industry network to undertake marketing activities for metal products such as copper and precious metals derived from e-scrap using DEScycle's technology. Additionally, MC will utilize its investment expertise to explore the expansion of the business together with DEScycle, aiming to contribute to the realization of a circular economy.*Proprietary technology developed by DEScycle uses Deep Eutectic Solvents (DES) to selectively dissolve metals at room temperature and atmospheric pressure.DEScycleDEScycle is a deep technology company developing disruptive metals processing technologies utilising a novel and eco-friendly class of chemistry known as DES. DES are recyclable liquid salts that allow for low-temperature, low-energy operations; resulting in low-carbon, low-impact metals. DEScycle’s technology can end the reliance upon high-energy pollutive processes like smelting and the use of highly toxic chemicals in the metals industry.Initially focused on the $100bn e-waste market, DEScycle’s mission is to commercialise a clearly differentiated recycling technology with industry leading costs, performance, environmental impact and transparency.About Mitsubishi CorporationMitsubishi Corporation is a global integrated business enterprise that develops and operates business together with its offices and subsidiaries worldwide. MC has eight Business Groups that operate across virtually every industry: Environmental Energy, Material Solution, Mineral Resources, Urban Development and Infrastructure, Mobility, Food Industry, Smart-Life Creation, and Power Solution.Inquiry RecipientMitsubishi CorporationTelephone:+81-3-3210-2171 Copyright 2025 JCN Newswire via SeaPRwire.com.

TOKYO, June 2, 2025 - (JCN Newswire via SeaPRwire.com) - JCB Co., Ltd., Japan's only global payment brand, is proud to announce that its exclusive cardmember mobile app, the MyJCB App, has been honored with the Gold Award in the Mobile Technologies, Applications, and Software Design category at the A' Design Award & Competition.This recognition follows the app’s recent success at the iF DESIGN AWARD 2025, making yet another significant milestone for the MyJCB App. The Gold Award is bestowed upon designs that place within the top 3% of all submissions, reflecting an exceptional standard of design excellence.The app’s service design and UI/UX design were developed in collaboration with FOURDIGIT Inc.Design Approach Focused on User ExperienceSince 2021, JCB has been collaborating with FOURDIGIT to enhance the MyJCB App through a comprehensive approach encompassing service design, UI/UX design, and the implementation of continuous improvement processes.As part of the renewal project, the team developed a strategy to define the app's role within the overall service experience, based on a detailed analysis of user behavior and challenges. They conducted surveys with thousands of users and in-depth interviews with over 50 participants to thoroughly examine credit card usage patterns and customer needs across various service channels, ultimately creating a comprehensive vision for cross-channel user experience.Following the renewal, the team has continued to enhance the app by leveraging app store feedback, user interviews, and usage data analysis, with the aim of creating an app that serves all customers, regardless of their level of financial literacy. They remain committed to delivering safer and more convenient card services while actively listening to customer feedback.For more information, please visit: https://www.4digit.com/en/projects/myjcbAbout MyJCB AppMyJCB is a web service exclusively for JCB cardmembers, offering features such as transaction history viewing, point balance checking, and security alert notifications. Launched in 2016, the MyJCB App underwent a significant renewal in November 2023 under the concept of "Card and App Integration." This renewal introduced enhanced visibility and accessibility, along with strengthened security features that reflect JCB's core value of customer safety and security—transforming the app into a more convenient and secure tool for cardmembers.The app enables users to sort transaction details by amount or date and features a keyword search function for seamless navigation. Its security features include "Card Usage Notifications" and "Security Status Recommendations," which suggest optimal security settings to support safe card usage.Continuously evolving through regular updates and feature enhancements, the app is designed to meet the diverse needs of all cardmembers, including digital concierge services for THE CLASS and Platinum cardmembers, as well as customizable app themes featuring four design options.For more information about the MyJCB App: https://www.jcb.co.jp/myjcb/app/index.htmlFor details about the Digital Concierge feature:https://www.jcb.co.jp/promotion/digital_concierge/index.htmlAbout A’ Design Award & CompetitionA' Design Award and Competition is one of the world’s largest, most prestigious and influential design accolades, one of the highest achievements in design. Entries are evaluated by an internationally influential jury panel composed of established scholars, prominent press members, creative design professionals, and experienced entrepreneurs. In the 2024–2025 edition, 1,821 winners from 115 countries were selected.Award summaryCategory: Mobile Technologies, Applications and Software DesignAward: Golden A' Design Awardhttps://competition.adesignaward.com/167269About JCB and FOURDIGITJCB Co., Ltd.JCB is a major global payment brand and a leading credit card issuer and acquirer in Japan. JCB launched its card business in Japan in 1961 and began expanding worldwide in 1981. Its acceptance network includes about 56 million merchants around the world. JCB Cards are now issued mainly in Asian countries and territories, with more than 169 million cardmembers. As part of its international growth strategy, JCB has formed alliances with hundreds of leading banks and financial institutions globally to increase its merchant coverage and cardmember base. As a comprehensive payment solution provider, JCB commits to providing responsive and high-quality service and products to all customers worldwide.For more information, please visit: www.global.jcb/en/FOURDIGIT Inc.FOURDIGIT is a design and tech company that provides essential 'design' to connect digital technology and people, creating comfortable experiences for everyone involved. Drawing on our expertise cultivated in Japan, we are expanding our services to regions across Asia where the demand for digital design is growing alongside economic development. Our objective is to deliver design and technology solutions that drive business success on a global scale. Our current office locations include Japan, Thailand, Vietnam, and Malaysia. Copyright 2025 JCN Newswire via SeaPRwire.com.

KAWASAKI, Japan, June 2, 2025 - (JCN Newswire via SeaPRwire.com) - Fujitsu Limited today announced its collaboration with Kawasaki City to launch a redevelopment project for the Fujitsu Technology Park in anticipation of its 90th anniversary in June 2025.Envisioned as an "Open Innovation & Technology Park," this initiative will foster connections between diverse stakeholders including – local government, the community, research institutions, and educational organizations – to cultivate an open environment where materiality initiatives and innovation can flourish. Building upon the spirit of Fujitsu's founding, the Fujitsu Technology Park will see a phased expansion, incorporating cutting-edge technology demonstration zones, environmental sustainability initiatives, and enhanced sports and wellness experiences. Fujitsu will promote this redevelopment with the aim of completion by 2035, coinciding with Fujitsu's centennial celebration.Redevelopment project overviewFujitsu initially embarked on a redevelopment plan in 2011 to elevate the Kawasaki Office (now Fujitsu Technology Park), a cornerstone of the company since its inception, into a world-class research and development campus. While this plan was temporarily paused for review in 2015, the demolition of outdated structures is currently underway.In the intervening years, Fujitsu has actively championed Kawasaki City's vision for a sustainable urban future, strengthening its partnership with the city. As a key milestone, in the first half of fiscal year 2024, Fujitsu consolidated its research and development departments and corporate functions into Fujitsu Technology Park and relocated its headquarters functions there. Furthermore, in January 2025, Fujitsu commenced the construction of a state-of-the-art, quantum computing facility as part of our research and development strategy for quantum computing. This facility will house one of the world's most powerful superconducting quantum computers, boasting 1,000 qubits, and is projected to be completed in fiscal year 2026.Redevelopment project conceptThe "Open Innovation & Technology Park" concept will be realized through phased redevelopment following the four distinct themes listed below.The overarching goal is to create an accessible, community-integrated, and walkable space.・Cultivation of a rich and sustainable environmentFujitsu aims to spearhead regional sustainability by implementing multifaceted initiatives, including promoting harmony with nature, conserving biodiversity, and creating green spaces to enhance resilience. The goal is for these initiatives to have a ripple effect throughout the region.・Connecting society through technology and innovationFujitsu is committed to collaborating with the local community to drive innovation, accelerate its social implementation, and enhance daily life.・Promotion of holistic well-being through sports and healthBy leveraging technology and data, Fujitsu seeks to create novel and engaging experiences centered on health and sports, contributing to overall well-being.・Honoring the founding spirit of innovationFujitsu will honor its founding spirit, deeply rooted in Kawasaki City, by accelerating materiality initiatives. This will be achieved by fostering connections between the Fujitsu Group, government agencies, and the local community through the Fujitsu Technology Park's redevelopment.Future plansA dedicated Fujitsu Sports zone will be established in the northwest corner of the site, featuring a newly constructed gymnasium, the Fujitsu Arena. By harnessing the power of technology and data, this area will provide engaging and novel sports experiences for all. The multi-purpose facility will also serve as a venue for company events and a temporary evacuation center for local residents in the event of a disaster.Step 2: Fujitsu Museum/Open Innovation (tentative name)As the gateway to the Fujitsu Technology Park, a multi-purpose facility will be constructed to connect customers, the community, and society with Fujitsu. The project also includes the development of a plaza near the station. This facility will house the Fujitsu Museum and serve as a welcoming space where people can gather, explore technology, ignite their creativity, and contribute to future innovations.Subsequent redevelopment phases after Step 1, Step 2 will be shared in due course, considering evolving circumstances and following consultations with stakeholders, including local residents.Fujitsu’s Commitment to the Sustainable Development Goals (SDGs)The Sustainable Development Goals (SDGs) adopted by the United Nations in 2015 represent a set of common goals to be achieved worldwide by 2030.Fujitsu’s purpose — “to make the world more sustainable by building trust in society through innovation” — is a promise to contribute to the vision of a better future empowered by the SDGs.About FujitsuFujitsu’s purpose is to make the world more sustainable by building trust in society through innovation. As the digital transformation partner of choice for customers around the globe, our 113,000 employees work to resolve some of the greatest challenges facing humanity. Our range of services and solutions draw on five key technologies: AI, Computing, Networks, Data & Security, and Converging Technologies, which we bring together to deliver sustainability transformation. Fujitsu Limited (TSE:6702) reported consolidated revenues of 3.6 trillion yen (US$23 billion) for the fiscal year ended March 31, 2025 and remains the top digital services company in Japan by market share. Find out more: global.fujitsuPress ContactsFujitsu LimitedPublic and Investor Relations DivisionInquiries Copyright 2025 JCN Newswire via SeaPRwire.com.

TOKYO, May 30, 2025 - (JCN Newswire via SeaPRwire.com) - Mitsubishi Corporation (MC) is pleased to announce it has established MC Global Innovation Inc. (MCGI) to serve as the operating company for its corporate venture capital (CVC) platform.Aligned with the “Create” pillar of MC’s Corporate Strategy 2027, MCGI will accelerate collaboration with startups and uncover business opportunities beyond MC’s existing domains. This is MC’s first company-wide CVC initiative.MCGI will make flexible investments across a broad range of sectors, with emphasis on areas with large future markets and high growth potential where MC can add distinctive value. It will build on technological insights and networks cultivated through industry-academia partnerships.To date, MC’s Business Groups have invested in startups closely linked to their current domains. With the new CVC company, MC’s total startup investment, including its existing commitments, will be approximately JPY 100 billion (about USD 700 million).Leveraging MC’s integrated strength, MCGI will offer portfolio companies tailored support that spans broad industry expertise, deep insights, customer access, and global networks, thereby facilitating commercialization, industrial application, and international expansion.Amid the growing uncertainty driven by rapid technological advances such as AI, MC will utilize MCGI to cultivate new pillars of growth and transform its business portfolio. Copyright 2025 JCN Newswire via SeaPRwire.com.

TOKYO, May 30, 2025 - (JCN Newswire via SeaPRwire.com) - Honda R&D Co., Ltd. (“Honda”), a research and development subsidiary of Honda Motor Co., Ltd., will co-develop a refueling port connecting system designed for on-orbit refueling of satellites, with Astroscale Japan Inc. (“Astroscale”), a subsidiary of Astroscale Holdings Inc.Honda will apply its mechatronics technologies amassed through its ongoing robotics research to co-develop the connecting system with an aim to integrate it with Astroscale RPOD (rendezvous, proximity operations and docking) technology so that it can be used in the technology demonstration of satellite refueling in low Earth orbit Astroscale is planning to conduct around 2029.Earth’s orbits are becoming increasingly congested due to the growing number of satellites and space debris, raising concerns that it may become difficult to sustainably use those orbits in the long term if no proactive measures are taken. To address this issue and achieve space sustainability, it is critical to move away from the traditional satellites and rockets developed for single use and establish a circular space economy based on the principles of “Reduce, Reuse, Repair, Refuel and Remove.” To this end, providing on-orbit services for satellites is considered one of the solutions.The two companies will co-develop a refueling port connecting system particularly for on-orbit satellite refueling, one of the key on-orbit services to enhance space sustainability. When on-orbit refueling becomes possible, it will extend the life of satellites and reduce both the number of satellites and the number of satellite launches. Moreover, by eliminating fuel constraints through refueling, satellites will gain greater range of missions and flexibility, enabling new ways of utilizing satellites.Honda R&D has been researching and developing robotics technologies that enable people to transcend various constraints such as time, place and human abilities and to augment people’s possibilities. Assuming that the range of human activities will expand into outer space in the future, Honda will strive to utilize its robotics technologies in various situations in outer space, such as applications of its remotely controlled robots on the lunar surface. For such applications, the technologies must function reliably even in the harsh environment of outer space. Co-developing the refueling port connecting system with Astroscale, the global market leader in on-orbit satellite servicing, will become the first step Honda takes toward acquiring technology that is practical for use in outer space.Comments by Keiji Otsu, President and Representative Director of Honda R&D Co., Ltd.“To this date, Honda has developed and delivered a wide range of products that provide mobility on land, in the water and in the skies. As our next frontier, we will take our challenges into the field of outer space and strive to offer value that makes people’s daily lives more enjoyable. Through the co-development of this refueling port connection system with Astroscale, Honda will contribute to space sustainability. Moreover, we will apply the practical technologies we gain through this co-development to our ongoing space-related research and development so that Honda technologies will contribute to the success of many space missions around the world.” Copyright 2025 JCN Newswire via SeaPRwire.com.

TOKYO, May 30, 2025 - (JCN Newswire via SeaPRwire.com) - IFS AB and NEC Corporation are strengthening their strategic partnership to create new value. Through this partnership, the two companies will further combine their strengths to accelerate the implementation of solutions in global markets, mutually enhance their resources and skills, and support the continued growth of their customers.As the leading provider of Industrial AI software, IFS provides companies worldwide with solutions to support manufacturing, supply chains, facility maintenance, and after-sales service operations.Since signing a partnership agreement with IFS in 1997, NEC has been offering IFS supply chain management services, such as NEC’s BluStellar (*1), a value creation model that supports the global business development of manufacturing customers based in Japan.Through the strengthening of this strategic partnership, the two companies will create new services that combine the assets of both companies, such as AI technology, and provide rapid cloud services with an enhanced delivery system.BackgroundSupply chain management has become increasingly important in recent years due to globalization and economic volatility. Companies are demanding greater supply chain visibility and flexibility to both manage risk and improve efficiency. Especially since the COVID pandemic, there has been a surge in technology investment to minimize supply chain disruptions.In this context, many companies are shifting to cloud solutions. Cloud technology is cost-effective and scalable, and its integration with AI and IoT provides a platform for automating operations and enabling predictive analytics. This shift to the cloud is essential to increase competitiveness in the global marketplace. At the same time, from an economic security perspective, cloud services are required to retain sovereignty and control over data and software in accordance with the laws and regulations of each country.This social background has led the two companies to announce the strengthening of this strategic partnership.Purpose of collaborationTo enhance the supply chain management that has been provided by both companies and expand IFS' diverse solutions, including "facility maintenance management" and "after-sales service operations," which are mainly provided to the manufacturing industry, to the aviation industry and other industries, thereby contributing to the realization of Digital Transforation (DX) for more customers.Provide flexible and secure cloud services, including new solutions that combine the assets of both companies, to customers in a timely manner.Specific efforts in the collaborationBuilding and Providing a Secure Cloud EnvironmentThe two companies will jointly build an environment for providing IFS Cloud (*2), IFS' component-based global ERP package, at a data center in Japan. This will provide a secure environment for customers seeking highly secure and reliable cloud services in Japan. NEC Inzai Data Center (*3), which provides a safe and secure cloud environment, is under consideration as one of the candidate data centers.Joint Development and Deployment of Next-Generation Services for the Japanese MarketThe two companies will leverage their respective strengths to continuously develop new services that meet the needs of the Japanese market. Specifically, NEC will provide its knowledge as a standard feature of IFS Cloud and develop a safe and secure upgrade method from IFS Applications to IFS Cloud. NEC will provide both new and existing customers with value-added services to support their transformations.Joint Development and Global Expansion of AI ServicesIFS and NEC will collaborate on cutting-edge AI technologies and solutions to develop new services. Through this collaboration, the two companies will accelerate the deployment of AI services in Japan and other global markets. Specifically, IFS will incorporate advanced AI solutions from NEC's BluStellar, including AI that automates the negotiation and coordination of procurement transactions with suppliers, into its own solutions and offer them to IFS' global customers. NEC will also use IFS' AI service, IFS.ai, to promote the use of AI by its customers in Japan, Asia, and elsewhere in the world.Strengthening Delivery SystemBoth companies will actively train highly skilled personnel and work together to strengthen the delivery system. This will enable us to provide faster and higher quality services to our customers.Through these efforts, the two companies will contribute to the realization of DX and business growth for both manufacturing and non-manufacturing customers in Japan and around the world.Mark Moffat, CEO of IFS AB, comments.IFS is honored to deepen our relationship with NEC and to launch an expanded, future-focused strategic partnership.Together, we have long supported the growth of manufacturing customers. Now, we are taking a bold step forward—extending our collaboration into high-growth industries such as aerospace, and scaling our joint offerings for the global market with advanced solutions like IFS POKA and IFS Copperleaf.By combining IFS’s industrial AI and global innovation with NEC’s deep market insight & experience, we are uniquely positioned to deliver transformative value at scale.As cloud adoption accelerates and regulatory demands intensify, our combined strengths will empower customers to drive smarter operations and achieve lasting business agility.This partnership is not just an evolution—it’s a commitment to go BIG, together.For our customers. For the industries we serve. And for the future we are building together.We are super excited about what lies ahead with partnership with NEC. Thank you.Comments from Takayuki Morita, President and CEO, NEC CorporationNEC has established a strong and longstanding partnership with IFS, having a proven track record of implementing IFS solutions across more than 200 companies spanning nearly 400 locations globally. We are delighted to announce our deepened commitment to strategically enhancing our partnership with IFS, focusing on empowering customers in Japan to achieve their global business ambitions.Through this joint endeavor, we will co-develop IFS Cloud’s cloud solutions in domestic data centers, enabling secure and reliable cloud environments tailored for customers in Japan. Furthermore, integrating NEC’s world-leading AI into IFS Cloud will drive new experiences and value creation for our customers.NEC also embraces the "Client Zero" approach by leveraging IFS’ solutions and innovations within our own organization to accelerate DX initiatives across the NEC Group's supply chain.Combining the respective strengths of NEC and IFS, we are committed to empowering continuous business growth for a wide range of industries, not only in Japan but globally.(1) "BluStellar" is a value creation model that leads customers into the future by realizing business model innovation and solving social issues and customer management issues through advanced cross-industry knowledge backed by proven results and NEC's cutting-edge technology honed through years of development and operation.https://jpn.nec.com/dx/index.html(2) IFS Cloudhttps://www.ifs.com/ifs-cloud/ifs-cloud-overview(3) NEC Inzai Data Centerhttps://jpn.nec.com/outsourcing/dc/inzai.html About IFSIFS is the world's leading provider of industrial AI and enterprise software for manufacturing, service, and hard-core businesses that power the planet. Our technology enables companies that manufacture goods, maintain complex assets, and manage service-centric operations to unleash the transformative power of Industrial AI™ to improve productivity, efficiency, and sustainability.IFS Cloud is a fully configurable, AI-powered platform designed to deliver ultimate flexibility and adaptability to your specific requirements and business evolution. Addressing the needs of Enterprise Resource Planning (ERP), Enterprise Asset Management (EAM), Supply Chain Management (SCM), Information Technology Service Management (ITSM), and Field Service Management (FSM), IFS' technology leverages AI, machine learning, real-time data, and analytics to help customers make informed strategic decisions. IFS technology leverages AI, machine learning, real-time data, and analytics to help customers make informed strategic decisions and achieve Moments of Service™.IFS was founded in 1983 by five college friends who pitched a tent outside the property of their first customer. They were available 24/7 and put their customers' needs first. Since then, IFS has grown into a global leader with more than 7,000 employees in 80 countries. Built on the core values of agility, customer centricity, and trust, IFS is recognized worldwide for delivering value and supporting strategic change. We are the most recommended supplier in our field. To find out why, visit ifs.com/en.About NECNEC Corporation has established itself as a leader in the integration of IT and network technologies while promoting the brand statement of "Orchestrating a brighter world." NEC enables businesses and communities to adapt to rapid changes taking place in both society and the market as it provides for the social values of safety, security, fairness and efficiency to promote a more sustainable world where everyone has the chance to reach their full potential. For more information, visit NEC at https://www.nec.com. Copyright 2025 JCN Newswire via SeaPRwire.com.

HIROSHIMA, Japan, May 29, 2025 - (JCN Newswire via SeaPRwire.com) - Mazda Motor Corporation's production and sales results for April 2025 are summarized below.I. Production1. Domestic ProductionMazda's domestic production volume in April 2025 decreased 12.6% year on year due to decreased production of passenger vehicles.[Domestic production of key models in April 2025]CX-5:25,554 units(up 16.8% year on year)CX-90:6,548 units(down 27.2%)MAZDA3:6,487 units(down 14.6%)2. Overseas ProductionMazda's overseas production volume in April 2025 increased 0.8% year on year due to increased production of passenger vehicles.[Overseas production of key models in April 2025]CX-50:11,807 units(up 8.3% year on year)CX-30:11,394 units(up 3.4%)MAZDA3:4,406 units(down 40.2%)II. Domestic SalesMazda's domestic sales volume in April 2025 increased 5.7% year on year due to increased sales of passenger and commercial vehicles.Mazda's market share was 3.8% (up 0.2 points year on year) in the registered vehicle market and 1.9% in the micro-mini vehicle market (down 0.7 points), thus its total market share was 3.1% (down 0.1 points).[Domestic sales of key models in April 2025]ROADSTER:1,916 units(up 124.1% year on year)MAZDA2:1,696 units(down 21.2%)CX-5:1,121 units(down 3.5%)III. ExportsMazda's export volume in April 2025 decreased 29.0% year on year due to decreased shipments to regions such as Europe and the North America.[Exports of key models in April 2025]CX-5:22,621 units(down 13.9% year on year)CX-90:6,326 units(down 22.8%)MAZDA3:5,269 units(down 29.2%)IV. Global SalesMazda's global sales volume in April 2025 increased 7.1% year on year due to increased sales in regions such as the USA.[Global sales of key models in April 2025]CX-5:26,153 units(down 0.6% year on year)CX-30:17,095 units(down 6.7%)MAZDA3:12,874 units(down 0.3%)* Overseas production figures are based on the number of Mazda-brand units that came off the production line (excluding CKD units)* Global production figures represent the total sum of domestic and overseas production volumes.* All information in this press release is as of the release date. No updates after that date are reflected. Copyright 2025 JCN Newswire via SeaPRwire.com.

TOKYO, May 28, 2025 - (JCN Newswire via SeaPRwire.com) - Eisai Co., Ltd. announced today that the in-house-discovered and developed orexin receptor antagonist DAYVIGO® (generic name: lemborexant) has been approved in China for the treatment of adults with insomnia, characterized by difficulties with sleep onset and/or sleep maintenance. Eisai plans to launch this medicine in China in the second quarter of fiscal year 2025.DAYVIGO is a dual orexin receptor antagonist that inhibits orexin neurotransmission regulating sleep-wake rhythm by binding competitively to the two subtypes of orexin receptors (OX1R and OX2R). DAYVIGO acts on the orexin neurotransmitter system and is believed to facilitate sleep onset, sleep maintenance, and wake by regulating sleep-wake rhythm. DAYVIGO binds to orexin receptors OX1R and OX2R and acts as a competitive antagonist with stronger inhibition effect on OX2R, which suppresses both REM and non-REM sleep drive, such that DAYVIGO may provide faster sleep onset and better sleep maintenance to patients.Eisai submitted an application for approval, which was accepted in January 2024, based on the outcome of two pivotal Phase 3 clinical studies (SUNRISE 1: NCT02783729(New Window) and SUNRISE 2: NCT02952820(New Window)) conducted globally in a total of approximately 2,000 adult patients with insomnia, as well as the outcome of a Phase 3 clinical study (Study 311: NCT04549168(New Window)) conducted in China.Insomnia is characterized by difficulty falling asleep, staying asleep, or both despite an adequate opportunity to sleep, that has occured at least three times a week for at least one month, and which can lead to fatigue, difficulty concentrating and irritability(1),(2). The prevalence of insomnia among adults in China is reported to be 15.0%(3), with approximately 172.5 million people thought to suffer from insomnia.(4)DAYVIGO has been approved for the treatment of insomnia in 22 countries and regions, including Japan and the United States, Canada, Australia and countries in Asia.Eisai will continue its efforts to deliver DAYVIGO as a new treatment option to insomnia patients across the world with the hope of contributing to restoration of daytime function and recovery for patients with insomnia by potentially delivering an active daytime life through fast sleep onset and good quality sleep.About DAYVIGO (Generic Name: Lemborexant)DAYVIGO, an orexin receptor antagonist, is Eisai’s in-house discovered and developed small molecule that inhibits orexin neurotransmission by binding competitively to the two subtypes of orexin receptors (orexin receptor 1 and 2). Fast on/off receptor kinetics of lemborexant to orexin receptors may influence lemborexant’s potential to facilitate improvements in sleep onset and maintenance with minimal morning residual effects. It has been approved for the treatment of insomnia in 22 countries including Japan, the United States, Canada, Australia and countries in Asia.(1) Ferrie JE, et al. Sleep epidemiology – a rapidly growing field. Int J Epidemiol. 2011;40(6):1431–1437.(2) Roth T. Insomnia: definition, prevalence, etiology and consequences. J Clin Sleep Med. 2007;3(5 Suppl):S7–S10.(3) Cao X-L, et al. The prevalence of insomnia in the general population in China: A meta-analysis. PLoS ONE 2017,12(2): e0170772.(4) Internal estimateMedia Inquiries:Public Relations Department,Eisai Co., Ltd.+81-(0)3-3817-5120 Copyright 2025 JCN Newswire via SeaPRwire.com.

KAWASAKI, Japan, May 28, 2025 - (JCN Newswire via SeaPRwire.com) - Fujitsu Limited today announced the successful completion of the acquisition of GK Software, which is now a wholly owned subsidiary of the Fujitsu Group.With the transaction now complete, a new and exciting chapter begins. GK, which currently serves more than a quarter of the world's top 50 retailers across 60 countries, has strong brand recognition in the retail industry, leading the global market with industry-leading POS and SaaS solutions including AI-powered price optimization. The two companies will strengthen their cooperation with Fujitsu contributing its technology to GK, including Fujitsu Kozuchi, Data Intelligence PaaS, and Dynamic SCM, and global delivery capabilities such as high-precision demand forecasting, which will increase added value for customers. GK’s retail technology will underpin the Consumer Experience pillar of Fujitsu Uvance – Fujitsu solutions that accelerate business and address societal challenges – and strengthen the Uvance proposition in the global retail market.There will be no changes to GK’s management structure. Michael Scheibner will continue to serve as CEO and Chairman of the Board, and Michael Jaszczyk will remain Chief Digital Transformation Officer, ensuring continuity in leadership and a strong foundation for the next phase of growth.Yoshinami Takahashi, Corporate Executive Officer, Corporate Vice President, COO, Head of Global Solutions, comments:“This marks a major step forward in Fujitsu’s transformation through Fujitsu Uvance and underlines our strong commitment to growth in key industries. We are excited about the opportunities ahead and confident that, together with GK, we will deliver even greater value to customers worldwide”.About FujitsuFujitsu’s purpose is to make the world more sustainable by building trust in society through innovation. As the digital transformation partner of choice for customers around the globe, our 113,000 employees work to resolve some of the greatest challenges facing humanity. Our range of services and solutions draw on five key technologies: AI, Computing, Networks, Data & Security, and Converging Technologies, which we bring together to deliver sustainability transformation. Fujitsu Limited (TSE:6702) reported consolidated revenues of 3.6 trillion yen (US$23 billion) for the fiscal year ended March 31, 2025, and remains the top digital services company in Japan by market share. Find out more: global.fujitsu.Press ContactsFujitsu LimitedPublic and Investor Relations DivisionInquiries Copyright 2025 JCN Newswire via SeaPRwire.com.

Toyota City, Japan, May 27, 2025 - (JCN Newswire via SeaPRwire.com) - Toyota Motor Corporation (Toyota) will begin construction on the Shinagawa Station West Exit Area District A New Construction Plan (tentative name; hereinafter, the "Plan"), which it is carrying out together with Keikyu Corporation (Keikyu), on May 31, 2025. Toyota will open a new Tokyo Head Office in FY2030 in a planned building located in front of Shinagawa Station, one of the most important transportation hubs in Japan.Toyota aims to fully transform itself into a mobility company that delivers smiles and happiness to people around the world, focusing on two major themes: carbon neutrality and expanding the value of mobility. The new Tokyo Head Office will be a key base in leading these initiatives and will be positioned as a place for people to gather and generate synergy. It will also serve as a center for collaborative creation with a diverse group of partners both inside and outside the company, thereby becoming a domestic and international hub.More specifically, it will be an engineer-first environment that serves as a development base for software, AI, and other forms of intelligence, complete with functions that enable development while seeing and touching actual mobility vehicles and a layout that enables open communication across all levels.In addition, Toyota will strive to enhance the facility's welfare benefit functions and consider implementing a Genki-KûkanTM*, where employees can work alongside plants, among other measures to create a space that encourages good workplace mental and physical well-being for staff to take on challenges.*A kûkan (space) research project that promotes well-being by incorporating the power of nature into daily life.It includes design research on the visual effect of plant leaf shapes, air quality research to clarify the function of microorganisms and chemical substances released by plants in the forest air, etcPrior to the start of construction, the company held a groundbreaking ceremony on May 23.Keikyu President Yukihiro Kawamata commented, "This year marks 100 years since our railway began operations in this area (Takanawa). As the first step towards the next 100 years, we are committed to collaborating with Toyota, a world-leading mobility company, to contribute to the development of Shinagawa as an international exchange hub that will play a leading role in Japan's future. Starting with this plan, we aim to gradually advance community development and transform the area around Shinagawa Station into a connection hub that moves the hearts of people and the world."Toyota President Koji Sato said, "The new Tokyo Head Office will be a key base for Toyota's transformation into a Mobility Company. We will create an environment where diverse talents can come together and unleash their creativity, accelerating our efforts to enrich lives through mobility. Furthermore, aiming to be 'Best-in-town,' we are committed to contributing to the further development of the Shinagawa Station area, firmly rooted in the local community."Toyota will continue to collaborate with Keikyu to take on urban development in the area. Copyright 2025 JCN Newswire via SeaPRwire.com.

Tokyo, London, and Paris, May 27, 2025 - (JCN Newswire via SeaPRwire.com) - JCB and PayXpert, a pioneering omnichannel payment services provider based in Europe and in the UK, today announced a strategic partnership to enhance JCB’s card acceptance across European1 and UK markets. The collaboration promises a smoother payment experience for both merchants in the regions and international JCB Cardmembers.Through this collaboration, JCB’s 169 million cardmembers will enjoy greater convenience and accessibility across a wide range of businesses throughout Europe and in the UK. PayXpert's varied merchant network is covering diverse sectors such as retail, hospitality, tourism, and transport. This partnership ensures broader JCB Card acceptance, making it easier than ever for JCB Cardmembers to use their preferred payment method while traveling and spending in Europe and in the UK.By joining JCB's merchant community of 56 million worldwide, PayXpert is ideally positioned to facilitate JCB Card acceptance in Europe and in the UK and support the growth of its merchant partners. This partnership will also enable PayXpert’s merchants to tap into the growing number of JCB Cardmembers, mainly from Asia, who frequently travel and shop across Europe. This way, merchants will be able to cater for the needs of international travellers and offer a more seamless and tailored in-store payment experience, encouraging repeat business and fostering loyalty. The collaboration will also facilitate cross-border payments, further enhancing convenience for both merchants and cardmembers. Moreover, JCB Card acceptance on POS terminals is enabled at no additional setup cost, empowering merchants to tap into new revenue opportunities effortlessly.“We are delighted to announce our new collaboration with PayXpert to further expand JCB’s presence in the European and UK market,” said Ray Shinzawa, Managing Director, JCB International (Europe) Ltd. “This partnership aligns with our goals of providing JCB Cardmembers with a fast and secure payment experience, whenever they need it. By leveraging PayXpert’s extensive network and expertise, we will further increase our JCB Card acceptance, providing unparalleled convenience for our cardmembers travelling throughout Europe.”Nicolas Riegert, Co-founder & CEO, PayXpert added, “We are thrilled to welcome JCB to our network and offer our merchants access to a wider customer base. This partnership showcases our commitment to providing seamless and flexible payment solutions that meet the evolving needs of our clients. Inclusivity is at the core of PayXpert’s DNA, and by accepting international payment methods like JCB, we enable more global shoppers to enjoy a payment experience tailored to their preferences and habits. By welcoming JCB Cardmembers, our merchants can attract new customers, increase sales, and enhance their overall customer experience.”About JCB JCB is a major global payment brand and a leading credit card issuer and acquirer in Japan. JCB launched its card business in Japan in 1961 and began expanding worldwide in 1981. Its acceptance network includes about 56 million merchants around the world. JCB Cards are now issued mainly in Asian countries and territories, with more than 169 million cardmembers. As part of its international growth strategy, JCB has formed alliances with hundreds of leading banks and financial institutions globally to increase its merchant coverage and cardmember base. As a comprehensive payment solution provider, JCB commits to providing responsive and high-quality service and products to all customers worldwide. For more information, please visit: www.global.jcb/en/About PayXpertPayXpert2 is a pioneer in omnichannel payments, subsidiary of Societe Generale group. We support local and international brands across various industries, providing services both online and in-store. We have developed services focused on revenue optimisation, performance enhancement, fraud prevention, as well as cross-border payments such as Discover or JCB, and alternative methods like Alipay+ and WeChat Pay. Our solutions also integrate inclusive features for the visually impaired. Our vision is to create a payment ecosystem that facilitates an inclusive commerce experience. www.payxpert.com MEDIA CONTACTS:JCB International (Europe) Ltd.Diana Lee: dlee@jcbeurope.euJCB (Head Office in Japan)Anna Takeda: Anna.Takeda@jcb.co.jp1 PayXpert Spain SL can facilitate the acceptance of JCB in the following countries in Europe: Austria, Belgium, Bulgaria, Cyprus, Estonia, France, Germany, Greece, Ireland, Italy, Luxembourg, Malta, Netherlands, Norway, Poland, Portugal, Czech Republic, Spain and Sweden.2 PayXpert is divided into PayXpert Limited and PayXpert Services Ltd, a subsidiary of the Societe Generale group, which includes PayXpert Spain SL and PayXpert France. PayXpert Limited is regulated by the FCA and licensed in the UK. PayXpert Spain is regulated by Banco de España and licensed in Spain. Copyright 2025 JCN Newswire via SeaPRwire.com.

TOKYO & JAKARTA, May 27, 2025 - (JCN Newswire via SeaPRwire.com) - JCB International Co., Ltd., the international operations subsidiary of JCB Co., Ltd., Japan's only international payment brand (hereinafter collectively referred to as “JCB”), has entered into a Memorandum of Understanding (MoU) with Noage International Inc. (hereinafter "NI"), a company engaged in medical and health checkup services. This partnership aims to expand the JCB Advanced Medical Tourism Program, which has been promoting advanced medical tourism to Japan for affluent Indonesians since 2023.On the same occasion, NI also signed an MoU with PT Bank Danamon Indonesia Tbk. As a result, Danamon Privilege Banking customers who hold Danamon JCB Precious Cards will receive the special service benefits of the JCB Exclusive Medical Tourism Program—benefits that are also available to JCB Indonesia Ultimate cardholders.Partnership OverviewMedical tourism is becoming increasingly popular among Indonesia's affluent segment, who are increasingly traveling abroad to access advanced medical services. While Singapore and Malaysia remain top destinations, Japan continues to face challenges, such as language barriers that limit access to its medical services.To overcome these challenges, JCB launched the JCB Advanced Medical Tourism Program in October 2023, initially offering services in Osaka for its affluent Indonesian cardmembers. In August 2024, the program expanded to Tokyo, further enhancing access to high-quality medical care in Japan.Through this partnership, JCB is expanding its services to offer cardmembers the option of receiving care at either Tokyo Midtown Clinic (Roppongi) or Nihonbashi Muromachi Mitsui Tower Midtown Clinic, both of which are affiliated with NI. Additionally, Ultimate cardmembers holding JCB Cards issued in Indonesia will be eligible for complimentary health checkup services at these two facilities.*English-language support will be provided throughout the entire process—from preliminary consultations to medical feedback—ensuring that cardmembers can receive continuous medical care with peace of mind.Furthermore, through JCB’s partner travel agency in Indonesia, assistance will be provided for all necessary arrangements related to medical visits to Japan, including flights, accommodations, and transportation. A special hospitality program will also be offered, featuring personalized sightseeing arrangements and access to JCB's exclusive privileges in Japan.*The health checkup provided by NI will be offered free of charge. However, to receive this service, cardmembers must select a health checkup option from the available menu (starting at 44,000 yen including tax). Further information is available at https://bit.ly/jcb_noageBackground of the MemorandumJCB has been issuing JCB Cards in Indonesia in collaboration with nine partners, primarily major banks, targeting affluent customers.With "Japanese hospitality (Omotenashi)" as the cornerstone of our global brand value, JCB has adopted “SUGOI JAPAN” as a key phrase in Indonesia. By fostering strong partnerships with numerous Japanese companies across both Indonesia and Japan, and leveraging its brand presence, JCB delivers the unique value of Japan to its cardmembers.This partnership with NI was made possible by the shared commitment of both companies to providing Japanese quality medical services in the Indonesian market.JCB will continue to enhance its distinctive and unique value under the "SUGOI JAPAN" initiative and strive to become the brand of choice for its cardmembers.The Concept of SUGOI JAPANJCB offers a range of exclusive services centered around the themes of "Japan" and "unique to JCB," based on three core concepts: "VISIT JAPAN," "JCB DAY," and "JAPAN DINNING.” JCB aims to ensure that its services are easy to understand and use for all cardmembers.Note: These services are limited to JCB Cards issued in Indonesia.About Noage InternationalNI is a company that aims to achieve “age-defying health and longevity,” a vision reflected in its name, “No age.” The company provides high-quality medical services for international patients at facilities, such as Tokyo Midtown Clinic.NI is committed to helping all customers lead healthy and fulfilling lives by offering personalized support that transcends language barriers. To achieve this, NI has developed a multilingual medical translation system powered by generative AI, enabling overseas patients to access medical services in Japan with peace of mind. (https://id.no-age.com/)About JCBJCB is a major global payment brand and a leading credit card issuer and acquirer in Japan. JCB launched its card business in Japan in 1961 and began expanding worldwide in 1981. Its acceptance network includes about 56 million merchants around the world. JCB Cards are now issued mainly in Asian countries and territories, with more than 169 million cardmembers. As part of its international growth strategy, JCB has formed alliances with hundreds of leading banks and financial institutions globally to increase its merchant coverage and cardmember base. As a comprehensive payment solution provider, JCB commits to providing responsive and high-quality service and products to all customers worldwide. For more information, please visit: https://bit.ly/JCBIndonesiaJPNContactAnna TakedaCorporate CommunicationsTel: +81-3-5778-8353Email: jcb-pr@info.jcb.co.jpAbout DanamonPT Bank Danamon Indonesia Tbk (“Danamon”) is one of Indonesia’s largest private-owned commercial banks with consolidated total assets of Rp250.8 trillion. With a vision of “We Care and Enable Millions to Prosper,” Danamon provides holistic financial solutions tailored for the needs of retail, small and medium enterprises, corporate, and financial institution customers. As a member of MUFG, one of the largest global financial groups, Danamon’s strength is supported by MUFG Bank, Ltd. as its parent entity, MUFG’s subsidiaries and partner banks in Southeast Asia, and group members in Indonesia: Adira Finance, Home Credit Indonesia, Mandala Finance, Zurich Asuransi Indonesia, alongside its other strategic partners.With more than 24,000 employees (consolidated), 870 branches (conventional, Sharia Business Unit, and Adira Finance) and 1.016 ATMs and CRMs across Indonesia alongside 60,000 ATM Bersama, PRIMA, and ALTO networks, online banking through D-Bank PRO for retail customers and Danamon Cash Connect for corporate customers, and Hello Danamon 1-500-090 24-hour contact center, Danamon is committed to growing together as One Financial Group, to become a trusted customer-centric financial partner, serve all stakeholders, and run a sustainable business for a better future for Indonesia.Danamon is listed on Indonesia Stock Exchange with the ticker code BDMN. MUFG Bank, Ltd. is Danamon’s controlling shareholder, owning 92.47% of Danamon’s shares (directly and indirectly). For further information, visit Danamon’s website, www.danamon.co.id.Note: Data as of March 31, 2025For more information, please contact:Tarida FransiskaCorporate Communications ManagerPT Bank Danamon Indonesia TbkEmail: tarida.fransiska@danamon.co.id Copyright 2025 JCN Newswire via SeaPRwire.com.

TOKYO, May 27, 2025 - (JCN Newswire via SeaPRwire.com) - Mitsubishi Heavy Industries, Ltd. (MHI) and the Ministry of Energy of Uzbekistan (MOE) have signed a Memorandum of Understanding (MOU) to conduct a joint study of a power development plan with stable power source needs, including the potential upgrade of the country's gas turbine fleet with hydrogen co-firing capability as well as other technologies that can contribute to decarbonization.Under this MOU, both entities have been working on the following three items:- Evaluation of an upgrade for existing power plants leveraging MHI equipment, to meet necessary parameters;- Evaluation of new gas turbine combined cycle (GTCC) plants, including hydrogen co-firing and scope of necessary modifications;- Capacity planning with latest technologies.The program was officially launched after the agreement on the detailed work plan between the MOE and MHI, and will continue for two years with financial support from the Ministry of Economy, Trade and Industry (METI) of Japan.Uzbekistan's government recently published its plan for introducing renewable power by 2030, which aims to achieve a generation ratio for renewables of more than 54% by that date. MHI has supplied systems for thermal power generation installations in Uzbekistan which are contributing toward generating stable power as demand increases; and which also offer a variety of decarbonization technologies such as hydrogen co-firing and carbon capture, utilization and storage (CCUS). Through this program, the MOE and MHI will evaluate the current plan and determine necessary countermeasures, including implementation of new systems and the modification of the current gas turbine fleet to supplement renewables introduction and promote further decarbonization.In January 2024, METI and the MOE concluded a Memorandum of Cooperation (MOC) to promote and enhance Japan-Uzbekistan energy cooperation in an effort to achieve a realistic energy transition that takes advantage of all available energy sources, technologies, and options, including energy conservation; renewable energy; hydrogen; ammonia; e-fuels; CCUS, carbon recycling; and highly efficient power generation technology. This program is in line with this MOC and promotes further collaboration between both countries.About MHI GroupMitsubishi Heavy Industries (MHI) Group is one of the world’s leading industrial groups, spanning energy, smart infrastructure, industrial machinery, aerospace and defense. MHI Group combines cutting-edge technology with deep experience to deliver innovative, integrated solutions that help to realize a carbon neutral world, improve the quality of life and ensure a safer world. For more information, please visit www.mhi.com or follow our insights and stories on spectra.mhi.com. Copyright 2025 JCN Newswire via SeaPRwire.com.

TOKYO, May 26, 2025 - (JCN Newswire via SeaPRwire.com) - Fujitsu Limited today announced the launch of its new corporate venture capital fund, Fujitsu Ventures Fund II(1) (Fund II), with a total capital commitment of 15 billion yen, effective July 1, 2025. This fund will be managed through Fujitsu Ventures Limited(2).Since April 2021, Fujitsu has been driving innovation through the establishment and management of Fujitsu Ventures Fund LLC (Fund I). Through Fund I, Fujitsu has made strategic business investments in startups globally to strengthen business collaboration aligned with its corporate strategy. Additionally, from June 2024, Fujitsu initiated impact investing, targeting startups that address social challenges. To date, Fund I has invested in a total of 17 companies and has achieved solid results in both strategic and financial aspects.Building on this foundation, Fund II will expand the scale of investments to enhance and develop these initiatives further. Fujitsu aims to accelerate innovation and contribute to the realization of a sustainable society through this new fund.Overview of Fund IIFund II will continue to invest in promising startups both domestically and internationally, following the approach of Fund I. Strategic business investments will focus on reinforcing business collaboration, while increasing investments in companies with cutting-edge technologies that hold potential for future business partnerships. This will accelerate Fujitsu’s ability to incorporate emerging technologies and trends.For impact investments, Fund II will prioritize contributions to solving social issues through its portfolio companies, while seeking to generate synergistic value through collaboration with Fujitsu.(1) Fujitsu Ventures Fund II：Managed within Fujitsu Ventures Fund LLC.(2) Fujitsu Ventures Limited：Head office: Minato-ku, TokyoPresident & CEO: Hideaki YajimaAbout FujitsuFujitsu’s purpose is to make the world more sustainable by building trust in society through innovation. As the digital transformation partner of choice for customers in over 100 countries, our 124,000 employees work to resolve some of the greatest challenges facing humanity. Our range of services and solutions draw on five key technologies: Computing, Networks, AI, Data & Security, and Converging Technologies, which we bring together to deliver sustainability transformation. Fujitsu Limited (TSE:6702) reported consolidated revenues of 3.7 trillion yen (US$26 billion) for the fiscal year ended March 31, 2024 and remains the top digital services company in Japan by market share. Find out more: global.fujitsu. Copyright 2025 JCN Newswire via SeaPRwire.com.

Kawasaki and Nagoya, Japan, May 23, 2025 - (JCN Newswire via SeaPRwire.com) - Fujitsu Limited and Tokai National Higher Education and Research System (THERS) today announced the successful completion of field trials using generative AI to process clinical data for use in the selection of clinical trial participants. The effort aims to address the issue ‘drug loss’ in Japan, i.e., a lack of availability of drugs used overseas due to stringent local approval requirements.In a clinical setting patient data can be broadly seperated into structured data, i.e., organized and quantifiable data such as vital signs and lab results, and unstructured data, i.e., data that lacks a predefined format such as doctors’ notes. Structuring unstructured clinical data has traditionally been a time-consuming manual process. These field trials used data from approximately 1,800 patient records of breast surgery procedures obtained from Nagoya University and Gifu University. Unstructured data was successfully structured at approximately 90% accuracy. Leveraging this newly structured data, a screening of three clinical trial projects identified 42 potential candidates, 27 of whom were actually eligible, potentially reducing patient selection time by approximately one-third. This enables faster decision-making and increases patient access to optimal clinical trials. Moving forward, both organizations will work to expand the number of target diseases and participating facilities, and improve the accuracy of this approach, while promoting its use in actual clinical trials.Fujitsu and THERS will further link the results of these field trials with Paradigm Health, Inc.’s state-of-the-art clinical trial platform to accelerate the use of real-world data (RWD). This will enable collaboration with medical institutions and pharmaceutical companies to enhance the planning and overall execution of clinical trials, and help mitigate drug loss in Japan.Future PlansTHERS aims to actively attract international joint clinical trials to the Japanese Tokai region and improve patients medical care by increasing operational efficiency and utilizing a clinical research environment for handling high-quality clinical data.On May 30, based on the results of these field trials, Fujitsu will expand its Healthy Living Platform and launch a function to promote the structuring and utilization of medical data using its AI service Fujitsu Kozuchi. This function will also be linked with the enterprise large language model (LLM) Takane in the future to support the advancement of data analysis in clinical research and the efficiency of patient selection.Fujitsu will continue to contribute to improving the overall performance of clinical research and the development of medical care in Japan under Fujitsu Uvance, its business model oriented around solving societal issues.About FujitsuFujitsu’s purpose is to make the world more sustainable by building trust in society through innovation. As the digital transformation partner of choice for customers in over 100 countries, our 124,000 employees work to resolve some of the greatest challenges facing humanity. Our range of services and solutions draw on five key technologies: Computing, Networks, AI, Data & Security, and Converging Technologies, which we bring together to deliver sustainability transformation. Fujitsu Limited (TSE:6702) reported consolidated revenues of 3.7 trillion yen (US$26 billion) for the fiscal year ended March 31, 2024 and remains the top digital services company in Japan by market share. Find out more: www.fujitsu.com.Press ContactsFujitsu LimitedPublic and Investor Relations DivisionInquiries Copyright 2025 JCN Newswire via SeaPRwire.com.

TOKYO, May 23, 2025 - (JCN Newswire via SeaPRwire.com) - Lockheed Martin, a global leader in the development and delivery of cutting-edge radar solutions, and Fujitsu Limited, a Japanese multinational leader in information and communications technology and digital services, today announced the conclusion of a Memorandum of Understanding (MOU) establishing Fujitsu as a source for the SPY-7 Subarray Suite Power Supply Line Replaceable Unit (PS LRU). Purchase orders in support of the Aegis System EquippedVessel program are anticipated later in 2025.Executive Perspectives“By locally manufacturing critical components for the SPY-7 radar, Japan can have complete confidence that this system will be fully supported and sustained for decades to come,” said. Paul Lemmo, vicepresident and general manager at Lockheed Martin. “We are honored to play a role in shaping the future of Japan's defense industry and proud to contribute to the growth of the defense employment landscape in the country.”“Fujitsu is honored to contribute to the manufacturing of the SPY-7 radar, especially in the production of the PS LRU, a critical component of the system,” said Tsuneo Hayashi, corporate executive officer, SEVP, Fujitsu Limited. “Fujitsu will further expand its collaboration with Lockheed Martin on the SPY-7 radar, contributing to its sustainment in Japan and helping to strengthen national security."Continued PartnershipIn 2024, the two companies signed a previous MOU to expand Lockheed Martin’s Industrial Cooperation goals for expanding its solid-state radar production and sustainment in Japan.The collaboration demonstrates Lockheed Martin’s commitment to growing the defense workforce and furtherdeveloping the production and sustainment of key components for its SPY-7 radar product line.For more than 30 years, Lockheed Martin has supported Japan’s national security through the delivery of highlycapable systems and sensors for the Kongo, Atago and Maya class destroyers. Lockheed Martin’s mission of expanding 21st Century Security® in Japan continues to be strengthened by the partnerships and relationships built in country.The SPY-7 Advantage: Elevating Naval Radar PerformanceLockheed Martin's SPY-7 solid-state radar technology empowers users to respond swiftly and decisively to evolving threats. With advanced detection and tracking capabilities, SPY-7 effectively counters complex threats, enabling simultaneous engagement of multiple targets.About Lockheed MartinLockheed Martin is a global defense technology company driving innovation and advancing scientific discovery. Ourall-domain mission solutions and 21st Century Security® vision accelerate the delivery of transformative technologies to ensure those we serve always stay ahead of ready. More information at LockheedMartin.com.About FujitsuFujitsu’s purpose is to make the world more sustainable by building trust in society through innovation. As the digitaltransformation partner of choice for customers around the globe, our 113,000 employees work to resolve some of the greatest challenges facing humanity. Our range of services and solutions draw on five key technologies: AI, Computing, Networks, Data & Security, and Converging Technologies, which we bring together to deliver sustainability transformation. Fujitsu Limited (TSE:6702) reported consolidated revenues of 3.6 trillion yen (US$23 billion) for the fiscal year ended March 31, 2025 and remains the top digital services company in Japan by market share. Find out more: www.fujitsu.com.Press Contacts:Lockheed MartinAsiaShorbani Royshorbani.roy@global.lmco.com+813 4563 8000 DomesticCara Hoaglundcara.a.hoaglund@lmco.com+1 856-206-3139Fujitsu Limited Public and Investor Relations DivisionGlobalLuke Happlefj-prhq@dl.jp.fujitsu.com Copyright 2025 JCN Newswire via SeaPRwire.com.

Ahmedabad, India, May 23, 2025 - (JCN Newswire via SeaPRwire.com) - Honda Motorcycle & Scooter India Pvt. Ltd. (HMSI), Honda’s motorcycle production and sales subsidiary in India, will build a fourth production line at its fourth plant (Vithalapur, Ahmedabad district, Gujarat). Planned to begin operation in 2027, the new line will have an annual production capacity of 650,000 units, bringing the total capacity of the fourth plant to 2.61 million units, making it Honda’s largest assembly plant for Honda motorcycles in the world.HMSI currently has four production plants in India with a total annual production capacity of 6.14 million units. In addition, the cumulative production volume reached 70 million units in April of this year, after 25 years since start of production in 2001.The fourth plant started operation in February 2016 with an annual production capacity of 600,000 units, and in June of the same year, the company expanded its capacity to 1.2 million units with the start of its second line. Furthermore, the third line started operation in January 2024, taking annual production capacity to 1.96 million units.Honda will be investing approximately 9.2 billion rupees (1 rupee = 1.75 yen, and approximately 16.1 billion Japanese yen) to construct a fourth line capable of producing 650,000 units of 125cc class motorcycles per year on the premises of the fourth plant.This will bring 1800 new jobs and increase the total production capacity of the fourth plant to 2.61 million units, making it one of Honda’s largest assembly plants for motorcycles in the world.In addition to the fourth production line at the fourth plant, HMSI’s total annual production capacity is expected to increase from the current 6.14 million units to approximately 7 million units in 2027 through further expansion of production capacity planned for other plants in India.Tsutsumu Otani, HMSI President & CEO“Honda has long been investing and expanding its production capacity in India, the world’s largest motorcycle market, to bring joy to its customers. 25 years on, with much support, HMSI has reached the milestone of 70 million units of cumulative production. With the additional investment in our fourth plant, Honda will continue to deliver attractive products and services to its customers around the world who have higher expectations and trust in the company, and further solidify its Indian motorcycle business.” Copyright 2025 JCN Newswire via SeaPRwire.com.

TOKYO, May 23, 2025 - (JCN Newswire via SeaPRwire.com) - Honda’s cumulative global production of engine/motor-powered motorcycles has reached 500 million units, 76 years after the company began mass production of motorcycles in 1949 with the Dream D-Type.Since its foundation in 1948, Honda has developed and offered products and services that meet the needs of customers in many countries and regions, based on its belief that “the purpose of technology is to make people’s lives easier."Honda began mass-production of motorcycles at its first overseas production facility in Belgium in 1963, and since then, has expanded its production globally in accordance with its fundamental principle of “producing locally where there is demand.” As a result, Honda achieved its 100 million-unit milestone in 1997, its 200 million-unit milestone in 2008, and its 300 million-unit milestone in 2014. In 2018, Honda’s annual production exceeded 20 million units for the first time in its history, and cumulative global production reached 400 million units in 2019. Although the annual production of motorcycles temporarily declined due to COVID-19 in 2020, demand has steadily recovered worldwide to pre-pandemic levels since then. In addition to internal combustion engine (ICE) models, Honda positioned year 2024 as its “first year of global expansion” for electric powered two-wheelers and has started launching new models, creating a wide and diverse product lineup.Honda now offers a broad variety of models from commuters for everyday use to larger displacement models for weekend leisure as well as electric vehicles, with an annual production capacity of more than 20 million units in 23 countries and regions and 37 production entities. The company deliver products and services to customers worldwide through a network of more than 30,000 Honda dealers.Honda will continue its efforts to further solidify its motorcycle business, by providing attractive products and services from diversified approach, realizing the “joy and freedom of mobility” for a wider range of customers, building a highly efficient business structure, and achieving carbon neutrality, including through electrification.Toshihiro Mibe, Director, President and Representative Executive Officer, Honda Motor Co., Ltd.“For Honda, motorcycle business is our founder’s business, and will continue to be the company’s core business. In the motorcycle business, we have built the trust of our customers through our many products and services, which has enabled us to achieve a cumulative production volume of 500 million units. I would like to thank our customers and all stakeholders who were involved in achieving this milestone, from development to production, sales, and service. Honda will continue to take on the challenge of expanding the joy of our customers around the world.”For more information, visit https://global.honda/en/newsroom/news/2025/c250522aeng.html. Copyright 2025 JCN Newswire via SeaPRwire.com.

TOKYO, May 23, 2025 - (JCN Newswire via SeaPRwire.com) - AISIN Corporation, DENSO CORPORATION, Toyota Tsusho Corporation, Toyota Motor Corporation, and Woven by Toyota, Inc. ("Five Toyota Group Companies") today announced the launch of the Toyota Software Academy to strengthen AI and software-centered human resource development. As a complementary effort, Toyota is also launching the Global AI Accelerator (GAIA) to significantly expand investments in AI research and development, accelerating innovation. Through both of these efforts, the Five Toyota Group Companies will collaborate to nurture AI and software professionals, and use AI to create better products (including AI-enabled products) aimed at achieving a society with safety, security, and freedom of mobility for all.1. Human Resource Development by the Toyota Software AcademyToyota Software Academy aims to nurture AI and software professionals who understand not only software technology but also hardware technology, embodying the essence of future automotive expertise.(1) Providing Practical Education Programs for Hands-On LearningFive Toyota Group Companies will offer about 100 training courses where participants can learn practical knowledge areas such as AI, data security, and vehicle regulations. For example, in the data-driven autonomous driving software development course, participants will learn knowledge as well as specialized AI and control theory, and by implementing their own programs in actual vehicles, they will gain hands-on experience in building cars that prioritize safety and quality while experiencing the joy of making cars.(2) Creating Opportunities for AI and Software Professionals Worldwide and Supporting Career DevelopmentFive Toyota Group Companies will bring together high-level AI and software professionals, providing opportunities to learn from each other and consider various career paths. Additionally, the academy will help participants' challenges by visualizing skills through collaboration with each company's career development system, such as DENSO's unique skill certification program, "SOMRIETM," and educational recommendations powered by AI.2. Toyota's Global AI Accelerator (GAIA)GAIA aims to rapidly accelerate the use of AI by significantly boosting investment in research, development, human resource development and implementation of AI systems throughout every part of Toyota. Rooted in the idea of Toyota's longstanding practice of Jidoka: automation with a human touch, GAIA's efforts will both amplify team member productivity and help create new AI-enabled products. GAIA will initially focus on 11 categories: AD/ADAS, Business Software Development, Customer Relations, Knowledge Retention and Transfer, In-Vehicle Agents, Material Discovery, Manufacturing, Novel Mobility, Office Productivity, Robotics, and Vehicle Engineering, with more categories planned.3. Comments from the Leaders of the Five CompaniesDr. Gill Pratt, Toyota's Chief Scientist said, "There is tremendous enthusiasm across global Toyota for leveraging AI to improve speed and efficiency in everything from manufacturing to design to office work, and to create new products that utilize AI. While we cannot predict the future, especially in AI, we can prepare for it and ensure we bring our best traditions to the table, putting people at the heart of technological change. By working together as one team, transcending organizational boundaries and national borders, we will provide greater value to our customers through AI and improve happiness for all."Yoshihisa Yamamoto, Chief Technology Strategy Officer of AISIN, stated that "We are advancing the development of more highly skilled engineers in the areas of vehicle actuators, control, and software, which are AISIN's strengths in order to realize our management philosophy of 'Bringing excitement to mobility and smiles to the future'. By participating in the Toyota Software Academy AISIN aims to cultivate many engineers who can develop technologies with a holistic view of the vehicle. This will contribute to the evolution of mobility technologies, including electrification and intelligence, and enable AISIN to provide attractive products to customers."Atsushi Hayashida, Chief Software Officer (CSwO) of DENSO said, "DENSO is not only advancing the in-vehicle software technology that we have developed over the past 40 years, but also providing opportunities for each and every software engineer to learn and grow so that they can continue to improve their knowledge and skills for the future mobility society where people everywhere can feel happy. We also provide a place for each software engineer to learn and grow so that they can continue to improve their knowledge and skills. In collaboration with the Academy, we will not only strengthen our own human resource development, but also contribute to the development of software human resources in the industry as a whole."Eiji Matsuzaki, Chief Executive Officer of the Digital Solutions Division at Toyota Tsusho, stated "Toyota Tsusho has been engaged in software development and engineer training primarily overseas. With the evolution of AI, the ways of developing software and the necessary knowledge and know-how are constantly changing, requiring not only an update of the knowledge and know-how accumulated so far but also further advancement. Through engineer training at the Toyota Software Academy, Toyota Tsusho aims to realize "global, human-centered software development" and contribute to the sustainable development of the automotive industry."Hiroaki Okuchi, Chief Customer Officer of Woven by Toyota said, "Woven by Toyota is working to build a safe, secure, and human-centered mobility society through software-driven technologies and business initiatives. Through this academy, we hope to share our strengths in areas like software and AI, and help develop the next generation of talent. We're excited to open up these efforts to many more like-minded partners so that we can grow and weave the future of mobility, together." Copyright 2025 JCN Newswire via SeaPRwire.com.

TOKYO, May 22, 2025 - (JCN Newswire via SeaPRwire.com) - Mitsubishi Heavy Industries, Ltd. (MHI) and Yamaha Motor Co., Ltd. (Yamaha Motor) are conducting joint research to develop a medium-sized multirotor unmanned aerial vehicle (hereinafter "medium-sized UAV") capable of carrying a payload of 200 kilograms. The two companies have conducted a flight test of a hybrid-type medium-sized UAV equipped with a compact, lightweight power generating unit developed by Yamaha Motor,(Note) and will continue joint research with the aim of utilizing a hybrid power system to extend the cruising range of the medium-sized UAV.MHI is leveraging the technologies it has cultivated through aircraft development and manufacturing to develop medium-sized UAVs. In March 2024, MHI concluded an agreement with Yamaha Motor to conduct joint research on utilizing the power generating unit that the company had developed, with the aim of utilizing a hybrid power system to extend the cruising range.This joint research will confirm the feasibility of using a power generating unit to realize a medium-sized UAV with a cruising range of 200 km and a maximum payload of 200 kg.MHI is engaged in the design, manufacture, and testing of a hybrid-type medium-sized UAV based on technology that it has cultivated through aircraft development and manufacturing. Yamaha Motor is working to develop a compact and lightweight power generating unit by combining technologies for the small, high-power engines that it has cultivated in its two- and four-wheeled vehicle engine business, with the latest electric motor technology.In a flight test conducted in mid-April at MHI's research facility, a medium-sized UAV equipped with a power generation unit developed by Yamaha Motor successfully lifted off for the first time.The prototype from this research will be exhibited at the MHI booth at the Japan Drone 2025 expo to be held at Makuhari Messe (Mihama-ku, Chiba) on June 4 (Wed.) - 6 (Fri.).In the future, medium-sized UAVs are expected to be routinely used to transport relief supplies to isolated areas, which has been a challenge in an era of frequent disasters, as an alternative to trucks and ships to improve logistics efficiency on routes such as remote islands and mountainous areas where logistics volume is low, and to transport materials in mountainous areas that are difficult to access by car, such as for construction and repair work on transmission towers.MHI will continue to work to offer solutions to various challenges by using UAVs, and contribute to the realization of a safe, secure, and comfortable world.The hybrid type uses electric power generated by an engine to drive the electric motors on each rotor.Specifications of the Medium-Sized UAVPayload (maximum): 200kgCruising range: 15km (battery type), 200km (hybrid type plan)Dimensions: Overall length approx. 6mMotive power: Battery type, Hybrid typeEase of transport: Can be transported by truck to takeoff/landing pointsAbout MHI GroupMitsubishi Heavy Industries (MHI) Group is one of the world’s leading industrial groups, spanning energy, smart infrastructure, industrial machinery, aerospace and defense. MHI Group combines cutting-edge technology with deep experience to deliver innovative, integrated solutions that help to realize a carbon neutral world, improve the quality of life and ensure a safer world. For more information, please visit www.mhi.com or follow our insights and stories on spectra.mhi.com. Copyright 2025 JCN Newswire via SeaPRwire.com.

TOKYO, May 21, 2025 - (JCN Newswire via SeaPRwire.com) - Eisai Co., Ltd. announced today the presentation of clinical research across its oncology portfolio and pipeline during the 2025 American Society of Clinical Oncology (ASCO) Annual Meeting (#ASCO25), which is taking place in Chicago, Illinois, and virtually,from May 30 to June 3.Notable data include findings from the Phase 3 LEAP-002 study, which evaluated lenvatinib(LENVIMA®), the orally available multiple receptor tyrosine kinase inhibitor (TKI) discovered by Eisai, plus pembrolizumab (KEYTRUDA®), MSD’s (Merck & Co., Inc., Rahway, NJ, USA) anti-PD-1 therapy, versus lenvatinib monotherapy for the first-line treatment of patients with unresectable hepatocellular carcinoma (HCC). The poster presentation will feature long-term follow-up data providing further insights into lenvatinib’s role in the treatment landscape for patients affected by HCC (NCT03713593;Abstract #4095).Additional research from Eisai's pipeline will focus on E7386, a CBP/β-catenin interaction inhibitor, in combination with lenvatinib. This includes a dose optimization trial-in-progress presentation (Abstract #TPS5632) and dose expansion findings (Abstract #5599) in patients with advanced or recurrent endometrial carcinoma (NCT04008797)."At Eisai, our pursuit of scientific advancement is fueled by a deep commitment to our human healthcare concept. We believe patients deserve our best efforts, and we endeavor to deliver that by pushing boundaries in oncology research, particularly in challenging areas," said Dr. Corina Dutcus, Senior Vice President, Oncology Global Clinical Development Lead at Eisai Inc. " Our data at ASCO 2025 showcase this principle in action. The long-term follow-up data from LEAP-002 contribute to our ongoing body of research and further reinforce our understanding of LENVIMA's established role in unresectable hepatocellular carcinoma, while our pipeline work in advanced endometrial carcinoma represents our continued dedication to addressing areas with unmet medical needs through innovative therapeutic approaches."An oral presentation will feature data from the final analysis of the Phase 3 LEAP-015 study evaluating lenvatinib plus pembrolizumab and chemotherapy versus chemotherapy in patients with advanced, metastatic gastroesophageal adenocarcinoma (NCT04662710; Abstract #4001).This release discusses investigational compounds and investigational uses for FDA-approved products.It is not intended to convey conclusions about efficacy and safety. There is no guarantee that any investigational compounds or investigational uses of FDA-approved products will successfully complete clinical development or gain FDA approval.The full list of Eisai presentations is included below. These abstracts will be made available via theASCO website on Thursday, May 22, 2025, at 4:00 PM Central Daylight Time (CDT).Cancer TypeStudy/CompoundAbstract TitleAbstract Type & DetailsLenvatinib Plus Pembrolizumab Gastrointestinal Cancer LEAP-002 LEAP-002 long-term follow-up: Lenvatinib plus pembrolizumab versus lenvatinib plus placebo for advanced hepatocellular carcinomaPoster SessionAbstract #4095May 31, 20259:00 AM CDT LEAP-015Lenvatinib plus pembrolizumab and chemotherapy versus chemotherapy in advanced, metastatic gastroesophageal adenocarcinoma: The Phase 3, randomizedLEAP-015 studyOral Abstract SessionAbstract #4001May 31, 20253:12 PM CDT Melanoma LEAP-003First-line lenvatinib plus pembrolizumab versus placebo plus pembrolizumab in Chinese patients with unresectable or metastatic melanoma: results from LEAP-003Poster SessionAbstract #9553May 31, 20259:00 AM CDTPipeline Gynecologic Cancer E7386Randomized study evaluating optimal dose, efficacy and safety of E7386 + lenvatinib versus treatment of physicians’ choice in advanced/recurrent endometrial carcinoma previously treated with anti-PD-(L)1 immunotherapyPoster SessionAbstract #TPS5632 June 1, 20259:00 AM CDTE7386 Study 102: Global dose-expansion cohort of E7386 + lenvatinib (LEN) in patients (pts) with advanced endometrial cancer (aEC) that progressed on platinum-based chemotherapy(chemo) and an anti-PD-(L)1 immunotherapy (IO)Poster SessionAbstract #5599June 1, 20259:00 AM CDT Pan-Tumor Systematic ReviewThe PRO-CTCAE in oncology clinical trials: Insights from a targeted literature review For Online PublicationIn March 2018, Eisai and MSD, through an affiliate, entered into a strategic collaboration for theworldwide co-development and co-commercialization of lenvatinib, both as monotherapy and in combination with pembrolizumab, MSD’s anti-PD-1 therapy. Eisai and MSD are studying the lenvatinibplus pembrolizumab combination through the LEAP (LEnvatinib And Pembrolizumab) clinical program inHCC and esophageal cancer across multiple clinical trials.Eisai’s Focus on CancerEisai positions Oncology as one of its key strategic areas, and aims to contribute to the cure of cancers through the discovery of innovative new drugs with new targets and mechanisms of action under the Deep Human BiologyLearning (DHBL) drug discovery and development organization.By utilizing biomarker data obtained from our products to elucidate the mechanisms of the incidence and root causes of cancer, as well as drug resistance, and using Eisai Group's precision chemistry technology to turn undruggable intracellular therapeutic targets into druggable ones, we will create new backbone therapeutic drugs.(1) KEYTRUDA® is a registered trademark of Merck Sharp & Dohme LLC., a subsidiary of Merck & Co., Inc., Rahway, NJ, USA.(2) E7386 is created through collaboration research between Eisai and PRISM BioLab Co., Ltd.(Headquarters: Kanagawa)(3) The presentation with TPS (Trial in Progress Submission) attached to the abstract number indicates that the study is in the intermediate stage, and the presentation does not report the final study results.Media Inquiries:Public Relations Department, Eisai Co., Ltd.+81-(0)3-3817-5120 Copyright 2025 JCN Newswire via SeaPRwire.com.

Toyota City, Japan, May 21, 2025 - (JCN Newswire via SeaPRwire.com) - Toyota Motor Corporation (Toyota) unveiled its new RAV4 to the world on May 21, with plans to launch the model in Japan before the end of FY2025.The RAV4 had its beginnings in 1994, when sport utility vehicles (SUVs) were positioned as off-road vehicles. It pioneered the crossover SUV genre for both on-and off-road driving. Since then, the RAV4 has evolved into a beloved model around the world. For five generations, it has continued to meet the changing lifestyles of the times.Launched in 2019, the fifth-generation RAV4 was developed to further enhance its unique appeal as a model for new lifestyles. It was developed on the concept of a "Robust Accurate Vehicle with 4 Wheel Drive" as a sophisticated blend of the power and utility of an SUV. It also adopted a new platform based on the Toyota New Global Architecture (TNGA), Toyota's structural innovation within the automobile manufacturing process. It delivered responsive driving performance with maneuverability and stability for any road surface.Under the concept of "Life is an Adventure, this sixth-generation RAV4 seeks to become a vehicle that allows any driver to enjoy an active lifestyle. The unique driving experience of the RAV4, which was further improved in the 5th generation, has been advanced with a newly developed hybrid system that enhances acceleration. The result is an evolved RAV4 that feels like it can go anywhere and do anything, with functionality and cutting-edge intelligent technology focused on ease-of use for the driver. The key to advancing vehicle intelligence is Arene, Toyota's first software development platform. By utilizing Arene, Toyota aims to achieve a greater level of safety and peace of mind, as well as enrich the mobility experience to make the new RAV4 a companion that fits seamlessly into various lifestyles, whether in urban living or outdoor adventures.Toyota will successively roll out the new RAV4 to customers in over 180 countries and regions globally.For more information, visit https://global.toyota/en/newsroom/toyota/42758168.html. Copyright 2025 JCN Newswire via SeaPRwire.com.

- Evaluation test to be conducted under actual operational conditions for one year from May- Methane oxidation rate of 70% or higher was confirmed in the initial performance, contributing significantly to reductions in GHG emissions from marine vesselsTOKYO, May 20, 2025 - (JCN Newswire via SeaPRwire.com) - Mitsubishi Heavy Industries Marine Machinery & Equipment Co, Ltd. (MHI-MME) of Mitsubishi Heavy Industries (MHI) Group, have begun demonstration testing for a methane oxidation(Note1) catalyst system for LNG-fueled marine vessels, being jointly developed with Daihatsu Infinearth Mfg. Co., Ltd.The demonstration test, which began in May this year in cooperation with KEYS Bunkering West Japan Ltd. (KEYS), involves installing the demonstration equipment on the LNG bunkering vessel(Note2) KEYS Azalea, owned and operated by that. KEYS Azalea was built by Mitsubishi Shipbuilding Co., Ltd.The catalyst system for the demonstration test oxidizes slip methane (unburned methane) contained in the exhaust gas of marine engines. Methane has a high greenhouse effect among GHGs,(Note3) so the ability to suppress its emission is a significant advantage of this system.The methane oxidation catalyst system was developed with MHI-MME's catalyst design and manufacturing technology at its core, combined with Mitsubishi Shipbuilding's shipboard installation technology, and Daihatsu Infinearth's engine optimization technology. Since an initial methane oxidation rate of 70% or higher has been verified in the onshore engine test, the demonstration testing will be conducted continuously for one year.MHI Group is making strategic efforts to strengthen its energy transition business. MHI-MME and Mitsubishi Shipbuilding are a part of this strategy, and amid the increasing urgency for global decarbonization, will continue to work to reduce GHG emissions from marine vessels, and contribute to the improvement of the environmental performance of ships on a global scale.(1) Methane oxidation is a chemical reaction in which methane (CH4) is converted into carbon dioxide (CO2) and water (H2O) through reaction with oxygen.(2) LNG bunkering vessels are small ships that supply LNG fuel to LNG-fueled vessels.(3) Greenhouse gases (GHGs) include carbon dioxide (CO2), methane (CH4), and nitrous oxide (N2O). The catalyst system for this demonstration test will only target slip methane.About MHI GroupMitsubishi Heavy Industries (MHI) Group is one of the world’s leading industrial groups, spanning energy, smart infrastructure, industrial machinery, aerospace and defense. MHI Group combines cutting-edge technology with deep experience to deliver innovative, integrated solutions that help to realize a carbon neutral world, improve the quality of life and ensure a safer world. For more information, please visit www.mhi.com or follow our insights and stories on spectra.mhi.com. Copyright 2025 JCN Newswire via SeaPRwire.com.

- New energy management system effectively uses onboard regenerative power, achieving energy savings during operation of around 10%- Elimination of power rail between stations and adoption of center guidance system significantly reduces infrastructure construction costs- Reduction of CO2 emissions by approximately over 40% during manufacturing and construction, as a result of a 97.5% reduction in CO2 emissions at Mihara MachineryTOKYO, May 19, 2025 - (JCN Newswire via SeaPRwire.com) - Mitsubishi Heavy Industries, Ltd. (MHI) has commercially launched Prismo, a more environmentally friendly Automated Guideway Transit (AGT) system,(Note1) as a new brand in the Crystal Mover family of fully automated driverless vehicle systems that the company has delivered worldwide since the 2000s. Prismo is the first AGT to utilize MHI's newly developed energy management system, which combines rapid charging at stations with onboard regenerative energy storage during operation to enhance energy efficiency. This eliminates the need for power rails between stations, realizing a simple system that will lead the world of fully automated and driverless transport to the next stage.This energy management system incorporates an Innovative Energy Storage Module named Mitsubishi High Power Battery, which being jointly developed by Musashi Energy Solutions Co., Ltd., and Mitsubishi Electric Corporation, customized for AGT systems.The adoption of this energy management system allows regenerative power generated during deceleration of the vehicle while in operation to be stored and utilized efficiently without being wasted, achieving energy savings in train operation of around 10% compared to conventional AGT systems,(Note2) and a reduction in CO2 emissions of approximately 10% throughout the operation phase. In addition, since there is no need for power rails between stations, in the event of a power outage, passengers can still be transported to the next station without hindrance.Further, Prismo utilizes a center guidance system that allows for a slimmer track design, significantly reducing civil engineering and other infrastructure construction costs, and contributing to improved aesthetics.(Note3) Fewer power Rails and guide rails also greatly reduce inspection and replacement work for electrical and track equipment, allowing for lower maintenance costs.In addition to the overall reduction in physical infrastructure costs, manufacturing of the rolling stock will be conducted at MHI's Carbon Neutral Transition Hub Mihara (Hiroshima Prefecture), which has reduced its CO2 emissions by 97.5% through measures such as supplying all necessary electricity for the factory from the Mitsubishi Heavy Industries Wadaoki Solar Power Plant. This will reduce CO2 emissions during the manufacture and construction of new transportation systems by more than 40% compared to conventional manufacturing.(Note2) Total CO2 emissions throughout the entire life cycle, including manufacturing, construction, and energy-efficient operation, as well as maintenance and disposal, will be reduced by approximately 6,400 tons compared to conventional products.(Note2)With the development of Prismo as an environmentally friendly system that contributes to reduced operating costs and improved aesthetics, MHI is continuing to advance the realization of a carbon-neutral society through initiatives in urban transportation.(1) Automated Guideway Transit (AGT) is an electric power-driven, fully automated transportation system. A key feature is the rubber-tired carriages that provide a smooth ride with low noise. AGT is used around the world for intra-city transportation, and moving people through airports and to surrounding areas. MHI has delivered numerous AGT systems in Japan and overseas.(2) Compared with MHI's existing AGT system, assuming the scale of the AGT systems previously delivered to airports.(3) In a center guidance system, the guide rails are located underneath the vehicle in the center, rather than at the sides. This halves the number of guide rails installed during construction, while also allowing for a slimmer track width and reduced costs.About MHI's AGT SystemsMHI has a long history of manufacturing transport vehicles, beginning with the production of passenger cars and streetcars in 1910, and supporting railway safety. The company has a proven track record in construction, operation, and maintenance of numerous AGT systems in the U.S. and Asia that make use of its accumulated technologies and environmental performance. These systems have the following features.- High degree of safety and availability: Systems equipped with brakes, air conditioning, and on-board management systems developed and manufactured in-house based on a proven track record and innovation, realizing long-term operational availability.- Mass transit: Mass transit is made possible without being affected by traffic congestion- Flexible timetables: Flexible operation according to demand- Environmental performance: Use of an electric drive system reduces the CO2 load of transportation per person- Compact design: Vehicles and tracks can be added and operated even in the narrow spaces of cities- Low-cost operation: Autonomous operation lessens the effort required to secure and train personnel, and reduces maintenance costsFor further information on Next-Generation AGT Prismo: www.mhi.com/products/engineering/prismo.htmlAbout MHI GroupMitsubishi Heavy Industries (MHI) Group is one of the world’s leading industrial groups, spanning energy, smart infrastructure, industrial machinery, aerospace and defense. MHI Group combines cutting-edge technology with deep experience to deliver innovative, integrated solutions that help to realize a carbon neutral world, improve the quality of life and ensure a safer world. For more information, please visit www.mhi.com or follow our insights and stories on spectra.mhi.com. Copyright 2025 JCN Newswire via SeaPRwire.com.

TOKYO, May 16, 2025 - (JCN Newswire via SeaPRwire.com) - Eisai Co., Ltd. announced today that it has received notification from Japan’s Ministry of Health, Labour, and Welfare (MHLW) that the “all-case surveillance” post-marketing observational study condition required at the time of approval of anticancer agent “Remitoro® for Intravenous Drip Infusion 300μg” (Denileukin Diftitox (Genetical Recombination)) for the indications of T-cell Lymphoma has been cleared.In March 2021, the MHLW approved “Remitoro” with the indications of “relapsed or refractory PeripheralT- cell Lymphoma (PTCL)” and “relapsed or refractory Cutaneous T-cell Lymphoma (CTCL)” , in Japan, with the following condition: “Because of the very limited number of subjects included in the Japanese clinical trials, the applicant is required to conduct a post-marketing observational study in all patients untildata from a certain number of patients is accumulated after its launch in the market, in order to identify thebackground information of patients treated with the product and collect safety and efficacy data on the product in the early post-marketing period, and thereby take necessary measures to ensure proper use of the product.”Based on the safety data in 111 patients and efficacy data in 85 patients submitted to the MHLW as the results of analyses of this all-case surveillance, the MHLW has concluded that the all-case surveillancewas conducted properly and the necessary measures to ensure proper use of the product weresufficient to lift the condition.Eisai will continually strive to promote the proper use of “Remitoro” and provide information about the product, thereby making further contributions to increase the benefits to patients and their families.About Remitoro for Intravenous Drip Infusion 300μg (Denileukin Diftitox (Genetical Recombination))This agent is a fusion protein consisting of interleukin-2 (IL-2) and partial sequence of diphtheria toxin. The antitumor effect of denileukin diftitox is believed to depend on specific binding to the IL-2 receptor on the surface of tumoral lymphocytes followed by intracellular delivery and release of diphtheria toxin fragment which inhibits proteinsynthesis and induce cell death.Eisai retains exclusive development and marketing rights for the agent in Japan and Asia.About Peripheral T-cell Lymphoma (PTCL)PTCL is a type of T-cell non-Hodgkin's lymphoma that is classified as an intermediate-grade lymphoma. PTCL isoften detected in advanced stages, and has symptoms such as swelling and lumps in the lymph nodes, fever, heavy night sweats, and weight loss. Among PTCLs, Anaplastic Lymphoma Kinase (ALK)-positive anaplastic largecell lymphoma, which occurs in the 20s and 30s, has a favorable prognosis and is curable. However, other types ofPTCL often occur around the age of 60, and may have a poor prognosis or be difficult to treat. Therefore, PTCL is still a disease with extremely high-unmet medical need. It is estimated that the number of patients with PTCL in Japan is less than 7,000.1About Cutaneous T-cell Lymphoma (CTCL)CTCL is a type of non-Hodgkin's lymphoma of primary cutaneous disease with various other manifestations in additional sites like lymph nodes and peripheral blood. In CTCL, some of the T cells (a type of lymphocyte involvedin the immune system) become cancerous, causing skin lesions and reducing the patient's QOL (Quality of Life) due to pain and pruritus. CTCL is generally a low-grade lymphoma, with initial patch and plaque skin lesions, but itprogresses slowly and advances to the tumor stage over several years to over a dozen years. CTCL is still a diseasewith extremely high unmet medical need because it has a high malignancy when it reaches the tumor stage and hasa poor prognosis. It is estimated that the number of patients with CTCL in Japan is less than 4,000.1About the results of “all-case surveillance” post-marketing observational studyThe specified post-marketing observational study is conducted for the purpose of collecting and confirming sideeffect incidence by symptom, quality, efficacy and safety information in pediatric, geriatric, pregnant patients, patients with renal dysfunction, hepatic dysfunction, patients who use the drug for a long time or those patients withany limitations or conditions in drug use.This study on Remitoro was conducted by central registration method to investigate the safety and efficacy of theagent, as well as factors that may affect them, in actual drug use under the approved conditions. The registered patients started administration of the drug for treatment within the period from May 2021 through September 2022 in86 medical facilities located in Japan. In the 111-safety analytical set, the common adverse drug reactions (ADRs)(incidence 10% or higher) were aspartate aminotransferase increased (22.5%), capillary leak syndrome (21.6%), alanine aminotransferase increased (21.6%), platelet count decreased (15.3%), hepatic function abnormal (14.4%)and pyrexia (13.5%).With respect to efficacy, the overall response rate in the 85 evaluable cases (70 cases in PTCL and 15 cases inCTCL) was 15.7% in PTCL, 20.0% in CTCL, and 16.5% in overall.(1) Vital Statistics/Patient Survey in 2023 (Health Statistics Office, Director-General for Statistics, Ministry of Health, Labour and Welfare, Japan.) (available in Japanese only) Copyright 2025 JCN Newswire via SeaPRwire.com.

Toyota City, Japan, May 16, 2025 - (JCN Newswire via SeaPRwire.com) - Toyota Motor Corporation (Toyota) announced that it will be expanding its battery electric vehicle (BEV) lineup in North America as part of Toyota's multi-pathway approach toward achieving a carbon-neutral society. The new bZ Woodland will premiere at a new vehicle launch event hosted by Toyota Motor North America (TMNA), a Toyota affiliate in North America, from May 19 to 21. The new bZ Woodland is scheduled to go on sale in North America in early 2026.The bZ4X Touring, the Japanese domestic model of the bZ Woodland is scheduled to launch(1) in Japan around spring 2026.Toward Carbon NeutralityToyota is committed to product and region-centered management with the aim of making ever-better cars. In developing powertrain systems to achieve carbon neutrality, various types of mobility are being rolled out as part of Toyota's multi-pathway approach offering electrified vehicle options tailored to customer needs in each country and region around the world.The U.S. market is expected to see steady growth, primarily in BEVs, and U.S. manufacturers have a high market share in BEVs. Therefore, it is necessary to further strengthen products. To accelerate the multi-pathway approach, Toyota is introducing the new bZ Woodland along with the bZ(2) and TOYOTA C-HR as a BEV lineup to cover SUVs, a major segment of the North American market.New bZ Woodland (North American specifications)The new bZ Woodland uses lithium-ion batteries with a total power capacity of 74.7 kWh(3)(4) to ensure a cruising range of approximately 260 miles(5) (AWD model), thanks in part to the highly efficient eAxle.It comes with battery pre-conditioning(6), with a development target of rapid charging in approximately 30 minutes(7) under cold conditions by maintaining the battery at a temperature optimal for charging.It uses NACS(8) as the rapid (DC) charging standard.The AWD model adopts a high-output type front and rear eAxle. In addition, the use of an evolved control system allows greater freedom in distributing front and rear driving force, achieving excellent driving stability even in outdoor situations.The new bZ Woodland features luggage space with a generous capacity of 30 cu.ft*3.It is scheduled to launch in North America in early 2026.(1) The partially redesigned bZ4X is also scheduled to launch in Japan the second half of 2025.(2) The North American model name for the bZ4X(3) Development target (North American specifications)(4) Calculated in accordance with IEC standard 62660-1(5) Development target value when driving in EPA mode (North American specifications)(6) A function that adjusts the battery temperature before rapid charging(7) Rapid charging time (North American specifications) at -10°C(8) NACS North American Charging SystemMoving forward, Toyota will continue to address customer needs in each region and contribute to carbon neutrality by developing various options―including HEVs, PHEVs, and FCEVs―while striving to make ever-better cars.A special Japanese website will be released today for the launch of the model for the Japanese market, with information updated as it becomes available. Copyright 2025 JCN Newswire via SeaPRwire.com.